EP3455377A2 - Epigenome-wide association study identifies cardiac developmental gene patterning and a novel class of biomarkers for heart failure - Google Patents
Epigenome-wide association study identifies cardiac developmental gene patterning and a novel class of biomarkers for heart failureInfo
- Publication number
- EP3455377A2 EP3455377A2 EP17739929.2A EP17739929A EP3455377A2 EP 3455377 A2 EP3455377 A2 EP 3455377A2 EP 17739929 A EP17739929 A EP 17739929A EP 3455377 A2 EP3455377 A2 EP 3455377A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- dcm
- methylation
- peripheral blood
- tissue
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010019280 Heart failures Diseases 0.000 title claims description 145
- 230000000747 cardiac effect Effects 0.000 title description 42
- 239000000090 biomarker Substances 0.000 title description 22
- 238000000059 patterning Methods 0.000 title description 5
- 108700029231 Developmental Genes Proteins 0.000 title 1
- 210000005259 peripheral blood Anatomy 0.000 claims abstract description 95
- 239000011886 peripheral blood Substances 0.000 claims abstract description 95
- 238000000034 method Methods 0.000 claims abstract description 79
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 63
- 201000010099 disease Diseases 0.000 claims abstract description 62
- 201000010046 Dilated cardiomyopathy Diseases 0.000 claims description 216
- 206010056370 Congestive cardiomyopathy Diseases 0.000 claims description 215
- 238000007069 methylation reaction Methods 0.000 claims description 157
- 230000011987 methylation Effects 0.000 claims description 154
- 230000014509 gene expression Effects 0.000 claims description 77
- 210000004369 blood Anatomy 0.000 claims description 69
- 239000008280 blood Substances 0.000 claims description 69
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 44
- 230000002107 myocardial effect Effects 0.000 claims description 39
- 239000003550 marker Substances 0.000 claims description 29
- 230000001973 epigenetic effect Effects 0.000 claims description 26
- 230000004075 alteration Effects 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 238000002560 therapeutic procedure Methods 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 8
- 238000004590 computer program Methods 0.000 claims description 8
- 238000004393 prognosis Methods 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 description 112
- 210000001519 tissue Anatomy 0.000 description 97
- 230000007067 DNA methylation Effects 0.000 description 80
- 239000000523 sample Substances 0.000 description 66
- 238000004458 analytical method Methods 0.000 description 38
- 108020004414 DNA Proteins 0.000 description 37
- 210000005003 heart tissue Anatomy 0.000 description 35
- 108020004999 messenger RNA Proteins 0.000 description 28
- 238000001574 biopsy Methods 0.000 description 27
- 230000010076 replication Effects 0.000 description 27
- 238000010606 normalization Methods 0.000 description 25
- 150000007523 nucleic acids Chemical group 0.000 description 24
- 241000282414 Homo sapiens Species 0.000 description 23
- 238000012163 sequencing technique Methods 0.000 description 23
- 238000012216 screening Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 230000002861 ventricular Effects 0.000 description 18
- 238000012795 verification Methods 0.000 description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 description 15
- 238000005259 measurement Methods 0.000 description 15
- 102400001263 NT-proBNP Human genes 0.000 description 14
- 210000000349 chromosome Anatomy 0.000 description 14
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 14
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 12
- 101001018034 Homo sapiens Lymphocyte antigen 75 Proteins 0.000 description 12
- 238000003559 RNA-seq method Methods 0.000 description 12
- 210000004165 myocardium Anatomy 0.000 description 12
- 101800001288 Atrial natriuretic factor Proteins 0.000 description 11
- 102400001282 Atrial natriuretic peptide Human genes 0.000 description 11
- 101800001890 Atrial natriuretic peptide Proteins 0.000 description 11
- 208000031229 Cardiomyopathies Diseases 0.000 description 11
- 101000780028 Homo sapiens Natriuretic peptides A Proteins 0.000 description 11
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 238000010200 validation analysis Methods 0.000 description 11
- KFVINGKPXQSPNP-UHFFFAOYSA-N 4-amino-2-[2-(diethylamino)ethyl]-n-propanoylbenzamide Chemical compound CCN(CC)CCC1=CC(N)=CC=C1C(=O)NC(=O)CC KFVINGKPXQSPNP-UHFFFAOYSA-N 0.000 description 10
- WBSMIPAMAXNXFS-UHFFFAOYSA-N 5-Nitro-2-(3-phenylpropylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCCC1=CC=CC=C1 WBSMIPAMAXNXFS-UHFFFAOYSA-N 0.000 description 10
- 102100027449 B9 domain-containing protein 1 Human genes 0.000 description 10
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 10
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 description 10
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 10
- 101000936600 Homo sapiens B9 domain-containing protein 1 Proteins 0.000 description 10
- 101000928278 Homo sapiens Natriuretic peptides B Proteins 0.000 description 10
- 102100034296 Natriuretic peptides A Human genes 0.000 description 10
- 102100036836 Natriuretic peptides B Human genes 0.000 description 10
- 238000013459 approach Methods 0.000 description 10
- NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 10
- 230000009067 heart development Effects 0.000 description 10
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 description 10
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 description 10
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 230000003827 upregulation Effects 0.000 description 9
- 206010003658 Atrial Fibrillation Diseases 0.000 description 8
- 108091029430 CpG site Proteins 0.000 description 8
- 101000653634 Homo sapiens T-box transcription factor TBX15 Proteins 0.000 description 8
- 102100035107 Neurotrimin Human genes 0.000 description 8
- 102100029853 T-box transcription factor TBX15 Human genes 0.000 description 8
- 238000004820 blood count Methods 0.000 description 8
- 230000002074 deregulated effect Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 210000000265 leukocyte Anatomy 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 108010042350 neurotrimin Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 238000003908 quality control method Methods 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 101001067187 Homo sapiens Plexin-A2 Proteins 0.000 description 7
- 101000782147 Homo sapiens WD repeat-containing protein 20 Proteins 0.000 description 7
- 102100034381 Plexin-A2 Human genes 0.000 description 7
- 102100036561 WD repeat-containing protein 20 Human genes 0.000 description 7
- 229940109239 creatinine Drugs 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 238000002592 echocardiography Methods 0.000 description 7
- 238000013507 mapping Methods 0.000 description 7
- 238000002493 microarray Methods 0.000 description 7
- 238000012070 whole genome sequencing analysis Methods 0.000 description 7
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 6
- 239000005541 ACE inhibitor Substances 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 6
- 108010014480 T-box transcription factor 5 Proteins 0.000 description 6
- 102100024755 T-box transcription factor TBX5 Human genes 0.000 description 6
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 6
- 239000002876 beta blocker Substances 0.000 description 6
- 229940097320 beta blocking agent Drugs 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 210000004413 cardiac myocyte Anatomy 0.000 description 6
- 238000012937 correction Methods 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000002483 medication Methods 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 238000007619 statistical method Methods 0.000 description 6
- 102000008873 Angiotensin II receptor Human genes 0.000 description 5
- 108050000824 Angiotensin II receptor Proteins 0.000 description 5
- 108091029523 CpG island Proteins 0.000 description 5
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 description 5
- 238000000692 Student's t-test Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 230000002596 correlated effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000003205 diastolic effect Effects 0.000 description 5
- 230000006607 hypermethylation Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 239000003087 receptor blocking agent Substances 0.000 description 5
- 238000012353 t test Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108091092584 GDNA Proteins 0.000 description 4
- 101001054649 Homo sapiens Latent-transforming growth factor beta-binding protein 2 Proteins 0.000 description 4
- 101001054646 Homo sapiens Latent-transforming growth factor beta-binding protein 3 Proteins 0.000 description 4
- 102100027017 Latent-transforming growth factor beta-binding protein 2 Human genes 0.000 description 4
- 101800001904 NT-proBNP Proteins 0.000 description 4
- 102100037415 Regulator of G-protein signaling 3 Human genes 0.000 description 4
- 101710140411 Regulator of G-protein signaling 3 Proteins 0.000 description 4
- 102100039775 Serine/threonine-protein kinase DCLK2 Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000008253 Systolic Heart Failure Diseases 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 238000012098 association analyses Methods 0.000 description 4
- 238000003339 best practice Methods 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 210000000746 body region Anatomy 0.000 description 4
- 230000017455 cell-cell adhesion Effects 0.000 description 4
- 238000002586 coronary angiography Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 230000003828 downregulation Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000006718 epigenetic regulation Effects 0.000 description 4
- 238000010195 expression analysis Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 108091070501 miRNA Proteins 0.000 description 4
- 239000002679 microRNA Substances 0.000 description 4
- 238000007481 next generation sequencing Methods 0.000 description 4
- 108091027963 non-coding RNA Proteins 0.000 description 4
- 102000042567 non-coding RNA Human genes 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 101150040471 19 gene Proteins 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 3
- 101150078651 Epha4 gene Proteins 0.000 description 3
- 102100021616 Ephrin type-A receptor 4 Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 108010033040 Histones Proteins 0.000 description 3
- 101000885387 Homo sapiens Serine/threonine-protein kinase DCLK2 Proteins 0.000 description 3
- 101000909641 Homo sapiens Transcription factor COE2 Proteins 0.000 description 3
- 101000857270 Homo sapiens Zinc finger protein GLIS1 Proteins 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 102100036721 Insulin receptor Human genes 0.000 description 3
- 108010011185 KCNQ1 Potassium Channel Proteins 0.000 description 3
- 108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 3
- 102100039124 Methyl-CpG-binding protein 2 Human genes 0.000 description 3
- 208000009525 Myocarditis Diseases 0.000 description 3
- 108060008487 Myosin Proteins 0.000 description 3
- 102000003505 Myosin Human genes 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102100037444 Potassium voltage-gated channel subfamily KQT member 1 Human genes 0.000 description 3
- 206010071436 Systolic dysfunction Diseases 0.000 description 3
- 102100024204 Transcription factor COE2 Human genes 0.000 description 3
- 102100025883 Zinc finger protein GLIS1 Human genes 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 210000003483 chromatin Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000007614 genetic variation Effects 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 238000009533 lab test Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000101 novel biomarker Substances 0.000 description 3
- 238000000513 principal component analysis Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- 102100027559 39S ribosomal protein L16, mitochondrial Human genes 0.000 description 2
- 102100039980 40S ribosomal protein S18 Human genes 0.000 description 2
- 102100031090 Alpha-catulin Human genes 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 102100033890 Arylsulfatase G Human genes 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 102100028236 BTB/POZ domain-containing protein KCTD5 Human genes 0.000 description 2
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
- 102100024154 Cadherin-13 Human genes 0.000 description 2
- 101100537629 Caenorhabditis elegans top-2 gene Proteins 0.000 description 2
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 2
- 208000006029 Cardiomegaly Diseases 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 241000219109 Citrullus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 102100020986 DNA-binding protein RFX5 Human genes 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 108060006698 EGF receptor Proteins 0.000 description 2
- 102100021454 Histone deacetylase 4 Human genes 0.000 description 2
- 101000650310 Homo sapiens 39S ribosomal protein L16, mitochondrial Proteins 0.000 description 2
- 101000811259 Homo sapiens 40S ribosomal protein S18 Proteins 0.000 description 2
- 101000922043 Homo sapiens Alpha-catulin Proteins 0.000 description 2
- 101000925538 Homo sapiens Arylsulfatase G Proteins 0.000 description 2
- 101001007242 Homo sapiens BTB/POZ domain-containing protein KCTD5 Proteins 0.000 description 2
- 101001075432 Homo sapiens DNA-binding protein RFX5 Proteins 0.000 description 2
- 101000899259 Homo sapiens Histone deacetylase 4 Proteins 0.000 description 2
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 2
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 2
- 101000977762 Homo sapiens Iroquois-class homeodomain protein IRX-5 Proteins 0.000 description 2
- 101000971665 Homo sapiens Kinesin-like protein KIF17 Proteins 0.000 description 2
- 101000893526 Homo sapiens Leucine-rich repeat transmembrane protein FLRT2 Proteins 0.000 description 2
- 101000629029 Homo sapiens Myosin regulatory light chain 2, ventricular/cardiac muscle isoform Proteins 0.000 description 2
- 101001067178 Homo sapiens Plexin-A4 Proteins 0.000 description 2
- 101000846284 Homo sapiens Pre-mRNA 3'-end-processing factor FIP1 Proteins 0.000 description 2
- 101001135391 Homo sapiens Prostaglandin E synthase Proteins 0.000 description 2
- 101000771012 Homo sapiens Protein CMSS1 Proteins 0.000 description 2
- 101000909855 Homo sapiens Protein CNPPD1 Proteins 0.000 description 2
- 101000686915 Homo sapiens Reticulophagy regulator 2 Proteins 0.000 description 2
- 101000610616 Homo sapiens Serine protease 27 Proteins 0.000 description 2
- 101000648174 Homo sapiens Serine/threonine-protein kinase 10 Proteins 0.000 description 2
- 101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 description 2
- 101000634900 Homo sapiens Transcriptional-regulating factor 1 Proteins 0.000 description 2
- 101000597923 Homo sapiens Transmembrane 7 superfamily member 3 Proteins 0.000 description 2
- 101000667337 Homo sapiens V-set and transmembrane domain-containing protein 4 Proteins 0.000 description 2
- 101000650148 Homo sapiens WD repeat domain phosphoinositide-interacting protein 1 Proteins 0.000 description 2
- 101000666502 Homo sapiens Xaa-Pro aminopeptidase 1 Proteins 0.000 description 2
- 101000759551 Homo sapiens Zinc finger and BTB domain-containing protein 47 Proteins 0.000 description 2
- 101000782132 Homo sapiens Zinc finger protein 217 Proteins 0.000 description 2
- 101000782300 Homo sapiens Zinc finger protein 827 Proteins 0.000 description 2
- 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 2
- 102100023529 Iroquois-class homeodomain protein IRX-5 Human genes 0.000 description 2
- 102100021529 Kinesin-like protein KIF17 Human genes 0.000 description 2
- 102100040899 Leucine-rich repeat transmembrane protein FLRT2 Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 108010080991 Mediator Complex Proteins 0.000 description 2
- 102000000490 Mediator Complex Human genes 0.000 description 2
- 241000288147 Meleagris gallopavo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 2
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 2
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 2
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 2
- 102100026925 Myosin regulatory light chain 2, ventricular/cardiac muscle isoform Human genes 0.000 description 2
- 108020001621 Natriuretic Peptide Proteins 0.000 description 2
- 102000004571 Natriuretic peptide Human genes 0.000 description 2
- 102100034385 Plexin-A4 Human genes 0.000 description 2
- 102100031755 Pre-mRNA 3'-end-processing factor FIP1 Human genes 0.000 description 2
- 102100033076 Prostaglandin E synthase Human genes 0.000 description 2
- 102100029154 Protein CMSS1 Human genes 0.000 description 2
- 102100024511 Protein CNPPD1 Human genes 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100024733 Reticulophagy regulator 2 Human genes 0.000 description 2
- 108091006694 SLC23A3 Proteins 0.000 description 2
- 102100040107 Serine protease 27 Human genes 0.000 description 2
- 102100028900 Serine/threonine-protein kinase 10 Human genes 0.000 description 2
- 102100034248 Solute carrier family 23 member 3 Human genes 0.000 description 2
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 2
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 2
- 101150107801 Top2a gene Proteins 0.000 description 2
- 102100034204 Transcription factor SOX-9 Human genes 0.000 description 2
- 102100029446 Transcriptional-regulating factor 1 Human genes 0.000 description 2
- 102100035339 Transmembrane 7 superfamily member 3 Human genes 0.000 description 2
- 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 2
- 102100024586 Tumor necrosis factor ligand superfamily member 14 Human genes 0.000 description 2
- 102100039764 V-set and transmembrane domain-containing protein 4 Human genes 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 102100027543 WD repeat domain phosphoinositide-interacting protein 1 Human genes 0.000 description 2
- 210000001766 X chromosome Anatomy 0.000 description 2
- 102100038365 Xaa-Pro aminopeptidase 1 Human genes 0.000 description 2
- 210000002593 Y chromosome Anatomy 0.000 description 2
- 102100023257 Zinc finger and BTB domain-containing protein 47 Human genes 0.000 description 2
- 102100036595 Zinc finger protein 217 Human genes 0.000 description 2
- 102100035802 Zinc finger protein 827 Human genes 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 239000002170 aldosterone antagonist Substances 0.000 description 2
- 229940083712 aldosterone antagonist Drugs 0.000 description 2
- 230000007227 biological adhesion Effects 0.000 description 2
- 239000000091 biomarker candidate Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 231100000457 cardiotoxic Toxicity 0.000 description 2
- 230000001451 cardiotoxic effect Effects 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000002790 cross-validation Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000011985 exploratory data analysis Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 108091008053 gene clusters Proteins 0.000 description 2
- 238000010209 gene set analysis Methods 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 208000018578 heart valve disease Diseases 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002171 loop diuretic Substances 0.000 description 2
- 108091085564 miR-25 stem-loop Proteins 0.000 description 2
- 108091080167 miR-25-1 stem-loop Proteins 0.000 description 2
- 108091083056 miR-25-2 stem-loop Proteins 0.000 description 2
- 108091044560 miR-635 stem-loop Proteins 0.000 description 2
- 238000005065 mining Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000000692 natriuretic peptide Substances 0.000 description 2
- 210000000933 neural crest Anatomy 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960001967 tacrolimus Drugs 0.000 description 2
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000011222 transcriptome analysis Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- PLVOEKQNBIXHDI-SBSPUUFOSA-N (2R)-2-amino-3-[(7-hydroxy-2-oxochromene-3-carbonyl)amino]propanoic acid hydrochloride Chemical compound Cl.N[C@H](CNC(=O)c1cc2ccc(O)cc2oc1=O)C(O)=O PLVOEKQNBIXHDI-SBSPUUFOSA-N 0.000 description 1
- 102100026210 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 Human genes 0.000 description 1
- 102100031548 18S rRNA aminocarboxypropyltransferase Human genes 0.000 description 1
- TYIRBZOAKBEYEJ-UHFFFAOYSA-N 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)ethyl 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate Chemical compound C1=CC(C)=CC=C1C(=O)C(N1C)=CC=C1CC(=O)OCCN1C(C(=O)N(C)C(=O)N2C)=C2N=C1 TYIRBZOAKBEYEJ-UHFFFAOYSA-N 0.000 description 1
- KXSKAZFMTGADIV-UHFFFAOYSA-N 2-[3-(2-hydroxyethoxy)propoxy]ethanol Chemical compound OCCOCCCOCCO KXSKAZFMTGADIV-UHFFFAOYSA-N 0.000 description 1
- 102100027451 4-hydroxybenzoate polyprenyltransferase, mitochondrial Human genes 0.000 description 1
- 102100033409 40S ribosomal protein S3 Human genes 0.000 description 1
- 102100025908 5-oxoprolinase Human genes 0.000 description 1
- 102100023818 ADP-ribosylation factor 3 Human genes 0.000 description 1
- 102100022886 ADP-ribosylation factor-like protein 4C Human genes 0.000 description 1
- 102100036027 ADP-sugar pyrophosphatase Human genes 0.000 description 1
- 102100025261 AMSH-like protease Human genes 0.000 description 1
- 108010088547 ARNTL Transcription Factors Proteins 0.000 description 1
- 102100034571 AT-rich interactive domain-containing protein 1B Human genes 0.000 description 1
- 102100035623 ATP-citrate synthase Human genes 0.000 description 1
- 102100029271 Acetylcholinesterase collagenic tail peptide Human genes 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 description 1
- 102100033764 Acyl-coenzyme A oxidase-like protein Human genes 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- 102100035990 Adenosine receptor A2a Human genes 0.000 description 1
- 102100024439 Adhesion G protein-coupled receptor A2 Human genes 0.000 description 1
- 102100026441 Adhesion G-protein coupled receptor D1 Human genes 0.000 description 1
- 102100040357 Angiomotin-like protein 1 Human genes 0.000 description 1
- 102400000345 Angiotensin-2 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 102100039379 Ankyrin repeat and SAM domain-containing protein 6 Human genes 0.000 description 1
- 102100033307 Ankyrin repeat domain-containing protein 37 Human genes 0.000 description 1
- 102100031366 Ankyrin-1 Human genes 0.000 description 1
- 102100031323 Anthrax toxin receptor 1 Human genes 0.000 description 1
- 101000693933 Arabidopsis thaliana Fructose-bisphosphate aldolase 8, cytosolic Proteins 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 102100028218 Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 Human genes 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 102100037211 Aryl hydrocarbon receptor nuclear translocator-like protein 1 Human genes 0.000 description 1
- 102100027708 Astrotactin-1 Human genes 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100026337 BAI1-associated protein 3 Human genes 0.000 description 1
- 101710049498 BAIAP3 Proteins 0.000 description 1
- 108700003785 Baculoviral IAP Repeat-Containing 3 Proteins 0.000 description 1
- 102100021662 Baculoviral IAP repeat-containing protein 3 Human genes 0.000 description 1
- 102100032305 Bcl-2 homologous antagonist/killer Human genes 0.000 description 1
- 108010040168 Bcl-2-Like Protein 11 Proteins 0.000 description 1
- 102000001765 Bcl-2-Like Protein 11 Human genes 0.000 description 1
- 102100023993 Beta-1,3-galactosyltransferase 5 Human genes 0.000 description 1
- 101150104237 Birc3 gene Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- 102100026346 Brain-specific angiogenesis inhibitor 1-associated protein 2 Human genes 0.000 description 1
- 102100026413 Branched-chain-amino-acid aminotransferase, mitochondrial Human genes 0.000 description 1
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 1
- 102100021390 C-terminal-binding protein 1 Human genes 0.000 description 1
- 102100026192 C-type lectin domain family 2 member L Human genes 0.000 description 1
- 102000014819 CACNA1B Human genes 0.000 description 1
- 108010017009 CD11b Antigen Proteins 0.000 description 1
- 102100030154 CDC42 small effector protein 1 Human genes 0.000 description 1
- 102100028244 COP9 signalosome complex subunit 7b Human genes 0.000 description 1
- 102100031187 COP9 signalosome complex subunit 9 Human genes 0.000 description 1
- 102100021975 CREB-binding protein Human genes 0.000 description 1
- 102100021288 CUE domain-containing protein 1 Human genes 0.000 description 1
- 102000004631 Calcineurin Human genes 0.000 description 1
- 108010042955 Calcineurin Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102100038563 Calcium-binding mitochondrial carrier protein Aralar1 Human genes 0.000 description 1
- 102100024436 Caldesmon Human genes 0.000 description 1
- 102100027313 Calsenilin Human genes 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- 102100024967 Caspase recruitment domain-containing protein 14 Human genes 0.000 description 1
- 102100028002 Catenin alpha-2 Human genes 0.000 description 1
- 102100022006 Cell division cycle protein 123 homolog Human genes 0.000 description 1
- 102100039118 Centromere/kinetochore protein zw10 homolog Human genes 0.000 description 1
- 102100036180 Centrosomal protein of 164 kDa Human genes 0.000 description 1
- 101710131445 Centrosomal protein of 164 kDa Proteins 0.000 description 1
- 102100034755 Centrosomal protein of 85 kDa Human genes 0.000 description 1
- 108050004729 Centrosomal protein of 85kDa Proteins 0.000 description 1
- 102100035244 Cerebellin-1 Human genes 0.000 description 1
- 102100025942 Chemokine-like protein TAFA-5 Human genes 0.000 description 1
- 102100034667 Chloride intracellular channel protein 1 Human genes 0.000 description 1
- 102100035954 Choline transporter-like protein 2 Human genes 0.000 description 1
- 102100035396 Cingulin-like protein 1 Human genes 0.000 description 1
- 241000272470 Circus Species 0.000 description 1
- 102100040935 Claudin-20 Human genes 0.000 description 1
- 102100031552 Coactosin-like protein Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102100034953 Coiled-coil domain-containing protein 68 Human genes 0.000 description 1
- 102100032373 Coiled-coil domain-containing protein 85B Human genes 0.000 description 1
- 102100027442 Collagen alpha-1(XII) chain Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102100030151 Complement C1q tumor necrosis factor-related protein 7 Human genes 0.000 description 1
- 102100025877 Complement component C1q receptor Human genes 0.000 description 1
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 102100029375 Crk-like protein Human genes 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 1
- 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 102100031007 Cytosolic non-specific dipeptidase Human genes 0.000 description 1
- 102100028697 D-glucuronyl C5-epimerase Human genes 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000026641 DNA hypermethylation Effects 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102100038587 Death-associated protein kinase 1 Human genes 0.000 description 1
- 102100033553 Delta-like protein 4 Human genes 0.000 description 1
- 102100022730 Diacylglycerol kinase gamma Human genes 0.000 description 1
- 102100039178 Dimethyladenosine transferase 1, mitochondrial Human genes 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 108010083068 Dual Oxidases Proteins 0.000 description 1
- 102100021217 Dual oxidase 2 Human genes 0.000 description 1
- 102100021076 Dynactin subunit 2 Human genes 0.000 description 1
- 102100032238 Dynein axonemal assembly factor 5 Human genes 0.000 description 1
- 102100024074 Dystrobrevin alpha Human genes 0.000 description 1
- 102100034745 E3 ubiquitin-protein ligase HERC2 Human genes 0.000 description 1
- 102100022409 E3 ubiquitin-protein ligase LNX Human genes 0.000 description 1
- 102100034830 E3 ubiquitin-protein ligase RNF216 Human genes 0.000 description 1
- 102100024739 E3 ubiquitin-protein ligase UHRF1 Human genes 0.000 description 1
- 102100029650 EH domain-binding protein 1-like protein 1 Human genes 0.000 description 1
- 101150077578 ELOVL2 gene Proteins 0.000 description 1
- 102100021558 ER lumen protein-retaining receptor 3 Human genes 0.000 description 1
- 102100027245 EVI5-like protein Human genes 0.000 description 1
- 102100031785 Endothelial transcription factor GATA-2 Human genes 0.000 description 1
- 101000823089 Equus caballus Alpha-1-antiproteinase 1 Proteins 0.000 description 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
- 102100031627 Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial Human genes 0.000 description 1
- 102100030969 Exocyst complex component 3-like protein Human genes 0.000 description 1
- 102100030862 Eyes absent homolog 2 Human genes 0.000 description 1
- 102100037583 FAST kinase domain-containing protein 5, mitochondrial Human genes 0.000 description 1
- 102100036089 Fascin Human genes 0.000 description 1
- 102100040612 Fermitin family homolog 3 Human genes 0.000 description 1
- 102100035323 Fibroblast growth factor 18 Human genes 0.000 description 1
- 102100036963 Filamin A-interacting protein 1-like Human genes 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 102100040134 Free fatty acid receptor 4 Human genes 0.000 description 1
- 102100039831 G patch domain-containing protein 3 Human genes 0.000 description 1
- 102100033050 GPN-loop GTPase 2 Human genes 0.000 description 1
- 102100040903 Gamma-parvin Human genes 0.000 description 1
- 102100034317 Geminin coiled-coil domain-containing protein 1 Human genes 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 102100034299 Germ cell-specific gene 1-like protein Human genes 0.000 description 1
- 102100040521 Golgi-associated kinase 1A Human genes 0.000 description 1
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241000630665 Hada Species 0.000 description 1
- 102100034047 Heat shock factor protein 4 Human genes 0.000 description 1
- 102100023937 Heparan sulfate glucosamine 3-O-sulfotransferase 1 Human genes 0.000 description 1
- 102100039383 Heparan-sulfate 6-O-sulfotransferase 1 Human genes 0.000 description 1
- 102100024025 Heparanase Human genes 0.000 description 1
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
- 102100028155 Heterogeneous nuclear ribonucleoprotein A1-like 2 Human genes 0.000 description 1
- 102100029009 High mobility group protein HMG-I/HMG-Y Human genes 0.000 description 1
- 102100025210 Histone-arginine methyltransferase CARM1 Human genes 0.000 description 1
- 102100022599 Homeobox protein Hox-C6 Human genes 0.000 description 1
- 102100034826 Homeobox protein Meis2 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000691589 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 Proteins 0.000 description 1
- 101000795618 Homo sapiens 18S rRNA aminocarboxypropyltransferase Proteins 0.000 description 1
- 101000725614 Homo sapiens 4-hydroxybenzoate polyprenyltransferase, mitochondrial Proteins 0.000 description 1
- 101000656561 Homo sapiens 40S ribosomal protein S3 Proteins 0.000 description 1
- 101000720962 Homo sapiens 5-oxoprolinase Proteins 0.000 description 1
- 101000684275 Homo sapiens ADP-ribosylation factor 3 Proteins 0.000 description 1
- 101000974390 Homo sapiens ADP-ribosylation factor-like protein 4C Proteins 0.000 description 1
- 101000595338 Homo sapiens ADP-sugar pyrophosphatase Proteins 0.000 description 1
- 101000648020 Homo sapiens AMSH-like protease Proteins 0.000 description 1
- 101000924255 Homo sapiens AT-rich interactive domain-containing protein 1B Proteins 0.000 description 1
- 101000782969 Homo sapiens ATP-citrate synthase Proteins 0.000 description 1
- 101000770471 Homo sapiens Acetylcholinesterase collagenic tail peptide Proteins 0.000 description 1
- 101000713904 Homo sapiens Activated RNA polymerase II transcriptional coactivator p15 Proteins 0.000 description 1
- 101000801174 Homo sapiens Acyl-coenzyme A oxidase-like protein Proteins 0.000 description 1
- 101000783751 Homo sapiens Adenosine receptor A2a Proteins 0.000 description 1
- 101000833358 Homo sapiens Adhesion G protein-coupled receptor A2 Proteins 0.000 description 1
- 101000718219 Homo sapiens Adhesion G-protein coupled receptor D1 Proteins 0.000 description 1
- 101000891169 Homo sapiens Angiomotin-like protein 1 Proteins 0.000 description 1
- 101000961279 Homo sapiens Ankyrin repeat and SAM domain-containing protein 6 Proteins 0.000 description 1
- 101000732539 Homo sapiens Ankyrin repeat domain-containing protein 37 Proteins 0.000 description 1
- 101000796140 Homo sapiens Ankyrin-1 Proteins 0.000 description 1
- 101000796095 Homo sapiens Anthrax toxin receptor 1 Proteins 0.000 description 1
- 101000724276 Homo sapiens Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 Proteins 0.000 description 1
- 101000936741 Homo sapiens Astrotactin-1 Proteins 0.000 description 1
- 101000798320 Homo sapiens Bcl-2 homologous antagonist/killer Proteins 0.000 description 1
- 101000904597 Homo sapiens Beta-1,3-galactosyltransferase 5 Proteins 0.000 description 1
- 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
- 101000766212 Homo sapiens Brain-specific angiogenesis inhibitor 1-associated protein 2 Proteins 0.000 description 1
- 101000766294 Homo sapiens Branched-chain-amino-acid aminotransferase, mitochondrial Proteins 0.000 description 1
- 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 1
- 101000912600 Homo sapiens C-type lectin domain family 2 member L Proteins 0.000 description 1
- 101000794295 Homo sapiens CDC42 small effector protein 1 Proteins 0.000 description 1
- 101000860489 Homo sapiens COP9 signalosome complex subunit 7b Proteins 0.000 description 1
- 101000922127 Homo sapiens COP9 signalosome complex subunit 9 Proteins 0.000 description 1
- 101000896987 Homo sapiens CREB-binding protein Proteins 0.000 description 1
- 101000894809 Homo sapiens CUE domain-containing protein 1 Proteins 0.000 description 1
- 101000762243 Homo sapiens Cadherin-13 Proteins 0.000 description 1
- 101000910297 Homo sapiens Caldesmon Proteins 0.000 description 1
- 101000726098 Homo sapiens Calsenilin Proteins 0.000 description 1
- 101000761167 Homo sapiens Caspase recruitment domain-containing protein 14 Proteins 0.000 description 1
- 101000859073 Homo sapiens Catenin alpha-2 Proteins 0.000 description 1
- 101000897353 Homo sapiens Cell division cycle protein 123 homolog Proteins 0.000 description 1
- 101000743902 Homo sapiens Centromere/kinetochore protein zw10 homolog Proteins 0.000 description 1
- 101000737277 Homo sapiens Cerebellin-1 Proteins 0.000 description 1
- 101000788164 Homo sapiens Chemokine-like protein TAFA-5 Proteins 0.000 description 1
- 101000946430 Homo sapiens Chloride intracellular channel protein 1 Proteins 0.000 description 1
- 101000737619 Homo sapiens Cingulin-like protein 1 Proteins 0.000 description 1
- 101000749339 Homo sapiens Claudin-20 Proteins 0.000 description 1
- 101000940352 Homo sapiens Coactosin-like protein Proteins 0.000 description 1
- 101000946607 Homo sapiens Coiled-coil domain-containing protein 68 Proteins 0.000 description 1
- 101000868814 Homo sapiens Coiled-coil domain-containing protein 85B Proteins 0.000 description 1
- 101000861874 Homo sapiens Collagen alpha-1(XII) chain Proteins 0.000 description 1
- 101000794269 Homo sapiens Complement C1q tumor necrosis factor-related protein 7 Proteins 0.000 description 1
- 101000933665 Homo sapiens Complement component C1q receptor Proteins 0.000 description 1
- 101000919315 Homo sapiens Crk-like protein Proteins 0.000 description 1
- 101000919690 Homo sapiens Cytosolic non-specific dipeptidase Proteins 0.000 description 1
- 101001058422 Homo sapiens D-glucuronyl C5-epimerase Proteins 0.000 description 1
- 101000956145 Homo sapiens Death-associated protein kinase 1 Proteins 0.000 description 1
- 101000872077 Homo sapiens Delta-like protein 4 Proteins 0.000 description 1
- 101001044807 Homo sapiens Diacylglycerol kinase gamma Proteins 0.000 description 1
- 101000889412 Homo sapiens Dimethyladenosine transferase 1, mitochondrial Proteins 0.000 description 1
- 101000902096 Homo sapiens Disks large homolog 4 Proteins 0.000 description 1
- 101001041190 Homo sapiens Dynactin subunit 2 Proteins 0.000 description 1
- 101000869175 Homo sapiens Dynein axonemal assembly factor 5 Proteins 0.000 description 1
- 101001053689 Homo sapiens Dystrobrevin alpha Proteins 0.000 description 1
- 101000872516 Homo sapiens E3 ubiquitin-protein ligase HERC2 Proteins 0.000 description 1
- 101000620132 Homo sapiens E3 ubiquitin-protein ligase LNX Proteins 0.000 description 1
- 101000734278 Homo sapiens E3 ubiquitin-protein ligase RNF216 Proteins 0.000 description 1
- 101000760417 Homo sapiens E3 ubiquitin-protein ligase UHRF1 Proteins 0.000 description 1
- 101001012961 Homo sapiens EH domain-binding protein 1-like protein 1 Proteins 0.000 description 1
- 101000898776 Homo sapiens ER lumen protein-retaining receptor 3 Proteins 0.000 description 1
- 101001057163 Homo sapiens EVI5-like protein Proteins 0.000 description 1
- 101001066265 Homo sapiens Endothelial transcription factor GATA-2 Proteins 0.000 description 1
- 101000866489 Homo sapiens Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial Proteins 0.000 description 1
- 101000938524 Homo sapiens Exocyst complex component 3-like protein Proteins 0.000 description 1
- 101000938438 Homo sapiens Eyes absent homolog 2 Proteins 0.000 description 1
- 101001028241 Homo sapiens FAST kinase domain-containing protein 5, mitochondrial Proteins 0.000 description 1
- 101001021925 Homo sapiens Fascin Proteins 0.000 description 1
- 101000749644 Homo sapiens Fermitin family homolog 3 Proteins 0.000 description 1
- 101000878128 Homo sapiens Fibroblast growth factor 18 Proteins 0.000 description 1
- 101000878301 Homo sapiens Filamin A-interacting protein 1-like Proteins 0.000 description 1
- 101000890672 Homo sapiens Free fatty acid receptor 4 Proteins 0.000 description 1
- 101001034106 Homo sapiens G patch domain-containing protein 3 Proteins 0.000 description 1
- 101000871114 Homo sapiens GPN-loop GTPase 2 Proteins 0.000 description 1
- 101000613555 Homo sapiens Gamma-parvin Proteins 0.000 description 1
- 101000926145 Homo sapiens Geminin coiled-coil domain-containing protein 1 Proteins 0.000 description 1
- 101001069989 Homo sapiens Germ cell-specific gene 1-like protein Proteins 0.000 description 1
- 101000893973 Homo sapiens Golgi-associated kinase 1A Proteins 0.000 description 1
- 101001023964 Homo sapiens Growth/differentiation factor 6 Proteins 0.000 description 1
- 101001016879 Homo sapiens Heat shock factor protein 4 Proteins 0.000 description 1
- 101001048058 Homo sapiens Heparan sulfate glucosamine 3-O-sulfotransferase 1 Proteins 0.000 description 1
- 101001035618 Homo sapiens Heparan-sulfate 6-O-sulfotransferase 1 Proteins 0.000 description 1
- 101001047819 Homo sapiens Heparanase Proteins 0.000 description 1
- 101001079106 Homo sapiens Heterogeneous nuclear ribonucleoprotein A1-like 2 Proteins 0.000 description 1
- 101000986380 Homo sapiens High mobility group protein HMG-I/HMG-Y Proteins 0.000 description 1
- 101001045154 Homo sapiens Homeobox protein Hox-C6 Proteins 0.000 description 1
- 101001019057 Homo sapiens Homeobox protein Meis2 Proteins 0.000 description 1
- 101001011421 Homo sapiens IQ domain-containing protein E Proteins 0.000 description 1
- 101000913079 Homo sapiens IgG receptor FcRn large subunit p51 Proteins 0.000 description 1
- 101000977638 Homo sapiens Immunoglobulin superfamily containing leucine-rich repeat protein Proteins 0.000 description 1
- 101000919167 Homo sapiens Inactive carboxypeptidase-like protein X2 Proteins 0.000 description 1
- 101001001416 Homo sapiens Inhibitor of growth protein 5 Proteins 0.000 description 1
- 101000852489 Homo sapiens Inositol 1,4,5-triphosphate receptor associated 1 Proteins 0.000 description 1
- 101001011985 Homo sapiens Inositol hexakisphosphate kinase 1 Proteins 0.000 description 1
- 101000962413 Homo sapiens Inositol polyphosphate-5-phosphatase A Proteins 0.000 description 1
- 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 1
- 101001078151 Homo sapiens Integrin alpha-11 Proteins 0.000 description 1
- 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 1
- 101000976713 Homo sapiens Integrin beta-like protein 1 Proteins 0.000 description 1
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 101001032345 Homo sapiens Interferon regulatory factor 8 Proteins 0.000 description 1
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
- 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 description 1
- 101000992298 Homo sapiens Kappa-type opioid receptor Proteins 0.000 description 1
- 101001091389 Homo sapiens Kelch-like protein 14 Proteins 0.000 description 1
- 101000945215 Homo sapiens Kelch-like protein 29 Proteins 0.000 description 1
- 101001139062 Homo sapiens Kinesin heavy chain isoform 5A Proteins 0.000 description 1
- 101000605496 Homo sapiens Kinesin light chain 1 Proteins 0.000 description 1
- 101000967589 Homo sapiens LRP2-binding protein Proteins 0.000 description 1
- 101000697493 Homo sapiens Large proline-rich protein BAG6 Proteins 0.000 description 1
- 101001047515 Homo sapiens Lethal(2) giant larvae protein homolog 1 Proteins 0.000 description 1
- 101001065853 Homo sapiens Leucine repeat adapter protein 25 Proteins 0.000 description 1
- 101001017828 Homo sapiens Leucine-rich repeat flightless-interacting protein 1 Proteins 0.000 description 1
- 101001065765 Homo sapiens Leucine-rich repeat transmembrane neuronal protein 1 Proteins 0.000 description 1
- 101001004868 Homo sapiens Leucine-rich repeat-containing protein 27 Proteins 0.000 description 1
- 101001064427 Homo sapiens Liprin-beta-2 Proteins 0.000 description 1
- 101001043594 Homo sapiens Low-density lipoprotein receptor-related protein 5 Proteins 0.000 description 1
- 101000958241 Homo sapiens LysM and putative peptidoglycan-binding domain-containing protein 1 Proteins 0.000 description 1
- 101001005464 Homo sapiens LysM and putative peptidoglycan-binding domain-containing protein 4 Proteins 0.000 description 1
- 101001052383 Homo sapiens MICAL-like protein 1 Proteins 0.000 description 1
- 101000956314 Homo sapiens Maleylacetoacetate isomerase Proteins 0.000 description 1
- 101001005667 Homo sapiens Mastermind-like protein 2 Proteins 0.000 description 1
- 101001017592 Homo sapiens Mediator of RNA polymerase II transcription subunit 13-like Proteins 0.000 description 1
- 101000955282 Homo sapiens Mediator of RNA polymerase II transcription subunit 27 Proteins 0.000 description 1
- 101000629088 Homo sapiens Mitochondria-eating protein Proteins 0.000 description 1
- 101000655000 Homo sapiens Mitochondrial import inner membrane translocase subunit Tim29 Proteins 0.000 description 1
- 101000764216 Homo sapiens Mitochondrial import receptor subunit TOM40 homolog Proteins 0.000 description 1
- 101001012646 Homo sapiens Monoglyceride lipase Proteins 0.000 description 1
- 101000623713 Homo sapiens Motile sperm domain-containing protein 3 Proteins 0.000 description 1
- 101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 description 1
- 101001000109 Homo sapiens Myosin-10 Proteins 0.000 description 1
- 101001000104 Homo sapiens Myosin-11 Proteins 0.000 description 1
- 101001072477 Homo sapiens N-acetylglucosamine-1-phosphotransferase subunit gamma Proteins 0.000 description 1
- 101000672316 Homo sapiens Netrin receptor UNC5B Proteins 0.000 description 1
- 101000973211 Homo sapiens Nuclear factor 1 B-type Proteins 0.000 description 1
- 101000598100 Homo sapiens Nuclear migration protein nudC Proteins 0.000 description 1
- 101000973960 Homo sapiens Nucleolar protein 3 Proteins 0.000 description 1
- 101001038562 Homo sapiens Nucleolar protein 4 Proteins 0.000 description 1
- 101001121964 Homo sapiens OCIA domain-containing protein 1 Proteins 0.000 description 1
- 101001121958 Homo sapiens OCIA domain-containing protein 2 Proteins 0.000 description 1
- 101000986786 Homo sapiens Orexin/Hypocretin receptor type 1 Proteins 0.000 description 1
- 101001134647 Homo sapiens PDZ and LIM domain protein 7 Proteins 0.000 description 1
- 101000572989 Homo sapiens POU domain, class 3, transcription factor 3 Proteins 0.000 description 1
- 101000613490 Homo sapiens Paired box protein Pax-3 Proteins 0.000 description 1
- 101000589392 Homo sapiens Pannexin-1 Proteins 0.000 description 1
- 101000693243 Homo sapiens Paternally-expressed gene 3 protein Proteins 0.000 description 1
- 101000955481 Homo sapiens Phosphatidylcholine translocator ABCB4 Proteins 0.000 description 1
- 101000595746 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Proteins 0.000 description 1
- 101000595751 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Proteins 0.000 description 1
- 101001137939 Homo sapiens Phosphorylase b kinase regulatory subunit beta Proteins 0.000 description 1
- 101000596046 Homo sapiens Plastin-2 Proteins 0.000 description 1
- 101000582936 Homo sapiens Pleckstrin Proteins 0.000 description 1
- 101000583225 Homo sapiens Pleckstrin homology domain-containing family H member 2 Proteins 0.000 description 1
- 101001035694 Homo sapiens Polyamine deacetylase HDAC10 Proteins 0.000 description 1
- 101000974732 Homo sapiens Potassium channel subfamily K member 17 Proteins 0.000 description 1
- 101000994632 Homo sapiens Potassium voltage-gated channel subfamily A member 2 Proteins 0.000 description 1
- 101000951948 Homo sapiens Probable ATP-dependent RNA helicase DDX56 Proteins 0.000 description 1
- 101000695548 Homo sapiens Probable proline-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101000745667 Homo sapiens Probable serine carboxypeptidase CPVL Proteins 0.000 description 1
- 101000612134 Homo sapiens Procollagen C-endopeptidase enhancer 1 Proteins 0.000 description 1
- 101000903791 Homo sapiens Procollagen galactosyltransferase 2 Proteins 0.000 description 1
- 101001070050 Homo sapiens Proline-rich basic protein 1 Proteins 0.000 description 1
- 101001123263 Homo sapiens Proline-serine-threonine phosphatase-interacting protein 1 Proteins 0.000 description 1
- 101001098833 Homo sapiens Proprotein convertase subtilisin/kexin type 6 Proteins 0.000 description 1
- 101000677836 Homo sapiens Protein ABHD13 Proteins 0.000 description 1
- 101000946275 Homo sapiens Protein CLEC16A Proteins 0.000 description 1
- 101001038314 Homo sapiens Protein ERGIC-53-like Proteins 0.000 description 1
- 101000875522 Homo sapiens Protein FAM110C Proteins 0.000 description 1
- 101000854603 Homo sapiens Protein FAM168A Proteins 0.000 description 1
- 101001027850 Homo sapiens Protein FAM53C Proteins 0.000 description 1
- 101001065830 Homo sapiens Protein LRATD1 Proteins 0.000 description 1
- 101001004752 Homo sapiens Protein LSM12 homolog Proteins 0.000 description 1
- 101000995300 Homo sapiens Protein NDRG2 Proteins 0.000 description 1
- 101000979599 Homo sapiens Protein NKG7 Proteins 0.000 description 1
- 101001094684 Homo sapiens Protein O-mannosyl-transferase 2 Proteins 0.000 description 1
- 101000835295 Homo sapiens Protein THEMIS2 Proteins 0.000 description 1
- 101000789727 Homo sapiens Protein YIPF2 Proteins 0.000 description 1
- 101000915575 Homo sapiens Protein ZNRD2 Proteins 0.000 description 1
- 101000972890 Homo sapiens Protein naked cuticle homolog 2 Proteins 0.000 description 1
- 101000825257 Homo sapiens Protein spinster homolog 3 Proteins 0.000 description 1
- 101000845257 Homo sapiens Protein tweety homolog 2 Proteins 0.000 description 1
- 101000784568 Homo sapiens Protein zyg-11 homolog B Proteins 0.000 description 1
- 101000996747 Homo sapiens Putative gonadotropin-releasing hormone II receptor Proteins 0.000 description 1
- 101000668140 Homo sapiens RNA-binding protein 8A Proteins 0.000 description 1
- 101000712982 Homo sapiens Ras association domain-containing protein 8 Proteins 0.000 description 1
- 101001089266 Homo sapiens Receptor-interacting serine/threonine-protein kinase 3 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000738765 Homo sapiens Receptor-type tyrosine-protein phosphatase N2 Proteins 0.000 description 1
- 101000606535 Homo sapiens Receptor-type tyrosine-protein phosphatase epsilon Proteins 0.000 description 1
- 101001075466 Homo sapiens Regulatory factor X-associated protein Proteins 0.000 description 1
- 101000727472 Homo sapiens Reticulon-4 Proteins 0.000 description 1
- 101000890554 Homo sapiens Retinal dehydrogenase 2 Proteins 0.000 description 1
- 101000602187 Homo sapiens Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta Proteins 0.000 description 1
- 101000731728 Homo sapiens Rho guanine nucleotide exchange factor 17 Proteins 0.000 description 1
- 101000752249 Homo sapiens Rho guanine nucleotide exchange factor 3 Proteins 0.000 description 1
- 101000617778 Homo sapiens SNF-related serine/threonine-protein kinase Proteins 0.000 description 1
- 101000727831 Homo sapiens SS18-like protein 2 Proteins 0.000 description 1
- 101000665140 Homo sapiens Scm-like with four MBT domains protein 2 Proteins 0.000 description 1
- 101000867466 Homo sapiens Segment polarity protein dishevelled homolog DVL-2 Proteins 0.000 description 1
- 101000864990 Homo sapiens Serine incorporator 5 Proteins 0.000 description 1
- 101000628575 Homo sapiens Serine/threonine-protein kinase 19 Proteins 0.000 description 1
- 101000697600 Homo sapiens Serine/threonine-protein kinase 32B Proteins 0.000 description 1
- 101000607339 Homo sapiens Serine/threonine-protein kinase ULK3 Proteins 0.000 description 1
- 101000740443 Homo sapiens Sodium channel modifier 1 Proteins 0.000 description 1
- 101000829425 Homo sapiens Steroid receptor RNA activator 1 Proteins 0.000 description 1
- 101000876149 Homo sapiens Synapse differentiation-inducing gene protein 1-like Proteins 0.000 description 1
- 101000673946 Homo sapiens Synaptotagmin-like protein 1 Proteins 0.000 description 1
- 101000666775 Homo sapiens T-box transcription factor TBX3 Proteins 0.000 description 1
- 101000648624 Homo sapiens TATA element modulatory factor Proteins 0.000 description 1
- 101000653587 Homo sapiens TBC1 domain family member 16 Proteins 0.000 description 1
- 101000801077 Homo sapiens TOM1-like protein 2 Proteins 0.000 description 1
- 101000762938 Homo sapiens TOX high mobility group box family member 4 Proteins 0.000 description 1
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 1
- 101000633632 Homo sapiens Teashirt homolog 3 Proteins 0.000 description 1
- 101000626153 Homo sapiens Tensin-3 Proteins 0.000 description 1
- 101000596743 Homo sapiens Testis-expressed protein 2 Proteins 0.000 description 1
- 101000794197 Homo sapiens Testis-specific serine/threonine-protein kinase 3 Proteins 0.000 description 1
- 101000847082 Homo sapiens Tetraspanin-9 Proteins 0.000 description 1
- 101000773122 Homo sapiens Thioredoxin domain-containing protein 5 Proteins 0.000 description 1
- 101000649064 Homo sapiens Thyrotropin-releasing hormone-degrading ectoenzyme Proteins 0.000 description 1
- 101000637851 Homo sapiens Tolloid-like protein 1 Proteins 0.000 description 1
- 101000837849 Homo sapiens Trans-Golgi network integral membrane protein 2 Proteins 0.000 description 1
- 101000805518 Homo sapiens Transcription cofactor vestigial-like protein 4 Proteins 0.000 description 1
- 101000757378 Homo sapiens Transcription factor AP-2-alpha Proteins 0.000 description 1
- 101000819088 Homo sapiens Transcription factor GATA-6 Proteins 0.000 description 1
- 101000979190 Homo sapiens Transcription factor MafB Proteins 0.000 description 1
- 101000651211 Homo sapiens Transcription factor PU.1 Proteins 0.000 description 1
- 101000825086 Homo sapiens Transcription factor SOX-11 Proteins 0.000 description 1
- 101000642514 Homo sapiens Transcription factor SOX-4 Proteins 0.000 description 1
- 101000648534 Homo sapiens Transmembrane 6 superfamily member 1 Proteins 0.000 description 1
- 101000851515 Homo sapiens Transmembrane channel-like protein 8 Proteins 0.000 description 1
- 101000638194 Homo sapiens Transmembrane emp24 domain-containing protein 4 Proteins 0.000 description 1
- 101000851660 Homo sapiens Transmembrane protein 147 Proteins 0.000 description 1
- 101000714762 Homo sapiens Transmembrane protein 176A Proteins 0.000 description 1
- 101000714756 Homo sapiens Transmembrane protein 176B Proteins 0.000 description 1
- 101000850794 Homo sapiens Tropomyosin alpha-3 chain Proteins 0.000 description 1
- 101000637036 Homo sapiens Tubulin polymerization-promoting protein family member 2 Proteins 0.000 description 1
- 101000830568 Homo sapiens Tumor necrosis factor alpha-induced protein 2 Proteins 0.000 description 1
- 101000799200 Homo sapiens Tumor necrosis factor alpha-induced protein 8-like protein 2 Proteins 0.000 description 1
- 101000939500 Homo sapiens UBX domain-containing protein 11 Proteins 0.000 description 1
- 101000662009 Homo sapiens UDP-N-acetylglucosamine pyrophosphorylase Proteins 0.000 description 1
- 101000809257 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 4 Proteins 0.000 description 1
- 101000643895 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 6 Proteins 0.000 description 1
- 101000900749 Homo sapiens Uncharacterized protein C14orf132 Proteins 0.000 description 1
- 101001028389 Homo sapiens Uncharacterized protein KIAA0895-like Proteins 0.000 description 1
- 101000841505 Homo sapiens Uridine-cytidine kinase 2 Proteins 0.000 description 1
- 101000639096 Homo sapiens V-type proton ATPase subunit e 2 Proteins 0.000 description 1
- 101000617919 Homo sapiens VPS10 domain-containing receptor SorCS1 Proteins 0.000 description 1
- 101000667209 Homo sapiens Vacuolar protein sorting-associated protein 72 homolog Proteins 0.000 description 1
- 101000935123 Homo sapiens Voltage-dependent N-type calcium channel subunit alpha-1B Proteins 0.000 description 1
- 101000997307 Homo sapiens Voltage-gated potassium channel subunit beta-2 Proteins 0.000 description 1
- 101000743193 Homo sapiens WD repeat-containing protein 27 Proteins 0.000 description 1
- 101000802348 Homo sapiens Zinc finger SWIM domain-containing protein 5 Proteins 0.000 description 1
- 101000964427 Homo sapiens Zinc finger and BTB domain-containing protein 14 Proteins 0.000 description 1
- 101000759241 Homo sapiens Zinc finger protein 138 Proteins 0.000 description 1
- 101000818754 Homo sapiens Zinc finger protein 18 Proteins 0.000 description 1
- 101000723601 Homo sapiens Zinc finger protein 528 Proteins 0.000 description 1
- 101000723603 Homo sapiens Zinc finger protein 529 Proteins 0.000 description 1
- 101000785605 Homo sapiens Zinc finger protein 653 Proteins 0.000 description 1
- 101000785641 Homo sapiens Zinc finger protein with KRAB and SCAN domains 1 Proteins 0.000 description 1
- 101000988424 Homo sapiens cAMP-specific 3',5'-cyclic phosphodiesterase 4B Proteins 0.000 description 1
- 101000988419 Homo sapiens cAMP-specific 3',5'-cyclic phosphodiesterase 4D Proteins 0.000 description 1
- 101000802101 Homo sapiens mRNA decay activator protein ZFP36L2 Proteins 0.000 description 1
- 101000798089 Homo sapiens tRNA (cytosine(38)-C(5))-methyltransferase Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102100029840 IQ domain-containing protein E Human genes 0.000 description 1
- 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- 102100023538 Immunoglobulin superfamily containing leucine-rich repeat protein Human genes 0.000 description 1
- 102100029326 Inactive carboxypeptidase-like protein X2 Human genes 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100035676 Inhibitor of growth protein 5 Human genes 0.000 description 1
- 102100036344 Inositol 1,4,5-triphosphate receptor associated 1 Human genes 0.000 description 1
- 102100030213 Inositol hexakisphosphate kinase 1 Human genes 0.000 description 1
- 102100039253 Inositol polyphosphate-5-phosphatase A Human genes 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 1
- 102100025320 Integrin alpha-11 Human genes 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 102100025390 Integrin beta-2 Human genes 0.000 description 1
- 102100023481 Integrin beta-like protein 1 Human genes 0.000 description 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
- 102100038069 Interferon regulatory factor 8 Human genes 0.000 description 1
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
- 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 description 1
- 102100031819 Kappa-type opioid receptor Human genes 0.000 description 1
- 102100034926 Kelch-like protein 14 Human genes 0.000 description 1
- 102100033557 Kelch-like protein 29 Human genes 0.000 description 1
- 102100020685 Kinesin heavy chain isoform 5A Human genes 0.000 description 1
- 102100038306 Kinesin light chain 1 Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 101150075124 LY75 gene Proteins 0.000 description 1
- 102100028047 Large proline-rich protein BAG6 Human genes 0.000 description 1
- 241000272168 Laridae Species 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 102100022956 Lethal(2) giant larvae protein homolog 1 Human genes 0.000 description 1
- 102100032097 Leucine repeat adapter protein 25 Human genes 0.000 description 1
- 102100033303 Leucine-rich repeat flightless-interacting protein 1 Human genes 0.000 description 1
- 102100031995 Leucine-rich repeat transmembrane neuronal protein 1 Human genes 0.000 description 1
- 102100025948 Leucine-rich repeat-containing protein 27 Human genes 0.000 description 1
- 102100031981 Liprin-beta-2 Human genes 0.000 description 1
- 102100021926 Low-density lipoprotein receptor-related protein 5 Human genes 0.000 description 1
- 102100038228 LysM and putative peptidoglycan-binding domain-containing protein 1 Human genes 0.000 description 1
- 102100025174 LysM and putative peptidoglycan-binding domain-containing protein 4 Human genes 0.000 description 1
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 1
- 102100024302 MICAL-like protein 1 Human genes 0.000 description 1
- 101150074995 MYL2 gene Proteins 0.000 description 1
- 102100038560 Maleylacetoacetate isomerase Human genes 0.000 description 1
- 102100025130 Mastermind-like protein 2 Human genes 0.000 description 1
- 201000008643 Meckel syndrome Diseases 0.000 description 1
- 102100034164 Mediator of RNA polymerase II transcription subunit 13-like Human genes 0.000 description 1
- 102100039001 Mediator of RNA polymerase II transcription subunit 27 Human genes 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 102100027034 Mitochondria-eating protein Human genes 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 102100032536 Mitochondrial import inner membrane translocase subunit Tim29 Human genes 0.000 description 1
- 102100026905 Mitochondrial import receptor subunit TOM40 homolog Human genes 0.000 description 1
- 102100029814 Monoglyceride lipase Human genes 0.000 description 1
- 102100023091 Motile sperm domain-containing protein 3 Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 208000021908 Myocardial disease Diseases 0.000 description 1
- 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 description 1
- 108091005975 Myofilaments Proteins 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 108010067385 Myosin Light Chains Proteins 0.000 description 1
- 102000016349 Myosin Light Chains Human genes 0.000 description 1
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 1
- 102100036640 Myosin-10 Human genes 0.000 description 1
- 102100036639 Myosin-11 Human genes 0.000 description 1
- 102100036713 N-acetylglucosamine-1-phosphotransferase subunit gamma Human genes 0.000 description 1
- 101150065403 NECTIN2 gene Proteins 0.000 description 1
- 108010018525 NFATC Transcription Factors Proteins 0.000 description 1
- 102000002673 NFATC Transcription Factors Human genes 0.000 description 1
- 101150114487 NPPB gene Proteins 0.000 description 1
- 102100035488 Nectin-2 Human genes 0.000 description 1
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 1
- 102100040289 Netrin receptor UNC5B Human genes 0.000 description 1
- 101100062772 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) dcl-2 gene Proteins 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 108010010424 Nuclear Factor 90 Proteins Proteins 0.000 description 1
- 102000015863 Nuclear Factor 90 Proteins Human genes 0.000 description 1
- 102100022165 Nuclear factor 1 B-type Human genes 0.000 description 1
- 102100036965 Nuclear migration protein nudC Human genes 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 102100022400 Nucleolar protein 3 Human genes 0.000 description 1
- 102100040316 Nucleolar protein 4 Human genes 0.000 description 1
- 102100027183 OCIA domain-containing protein 1 Human genes 0.000 description 1
- 102100027182 OCIA domain-containing protein 2 Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102100028141 Orexin/Hypocretin receptor type 1 Human genes 0.000 description 1
- 108700005081 Overlapping Genes Proteins 0.000 description 1
- 102100033337 PDZ and LIM domain protein 7 Human genes 0.000 description 1
- 102100026456 POU domain, class 3, transcription factor 3 Human genes 0.000 description 1
- 102100040891 Paired box protein Pax-3 Human genes 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 102100032361 Pannexin-1 Human genes 0.000 description 1
- 102100025757 Paternally-expressed gene 3 protein Human genes 0.000 description 1
- 102100039032 Phosphatidylcholine translocator ABCB4 Human genes 0.000 description 1
- 102100036056 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human genes 0.000 description 1
- 102100036052 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human genes 0.000 description 1
- 102100020854 Phosphorylase b kinase regulatory subunit beta Human genes 0.000 description 1
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
- 102100030264 Pleckstrin Human genes 0.000 description 1
- 102100030360 Pleckstrin homology domain-containing family H member 2 Human genes 0.000 description 1
- 102100039388 Polyamine deacetylase HDAC10 Human genes 0.000 description 1
- 102100022757 Potassium channel subfamily K member 17 Human genes 0.000 description 1
- 102100034369 Potassium voltage-gated channel subfamily A member 2 Human genes 0.000 description 1
- 241000677647 Proba Species 0.000 description 1
- 102100037427 Probable ATP-dependent RNA helicase DDX56 Human genes 0.000 description 1
- 102100028531 Probable proline-tRNA ligase, mitochondrial Human genes 0.000 description 1
- 102100039310 Probable serine carboxypeptidase CPVL Human genes 0.000 description 1
- 102100041026 Procollagen C-endopeptidase enhancer 1 Human genes 0.000 description 1
- 102100022973 Procollagen galactosyltransferase 2 Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 1
- 102100034288 Proline-rich basic protein 1 Human genes 0.000 description 1
- 102100029026 Proline-serine-threonine phosphatase-interacting protein 1 Human genes 0.000 description 1
- 102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 description 1
- 102100021500 Protein ABHD13 Human genes 0.000 description 1
- 102100034718 Protein CLEC16A Human genes 0.000 description 1
- 102100040251 Protein ERGIC-53-like Human genes 0.000 description 1
- 102100035979 Protein FAM110C Human genes 0.000 description 1
- 102100020938 Protein FAM168A Human genes 0.000 description 1
- 102100037526 Protein FAM53C Human genes 0.000 description 1
- 108091008611 Protein Kinase B Proteins 0.000 description 1
- 108010015499 Protein Kinase C-theta Proteins 0.000 description 1
- 102100032095 Protein LRATD1 Human genes 0.000 description 1
- 102100025612 Protein LSM12 homolog Human genes 0.000 description 1
- 102100034436 Protein NDRG2 Human genes 0.000 description 1
- 102100023370 Protein NKG7 Human genes 0.000 description 1
- 102100028655 Protein O-mannose kinase Human genes 0.000 description 1
- 101710086532 Protein O-mannose kinase Proteins 0.000 description 1
- 102100035490 Protein O-mannosyl-transferase 2 Human genes 0.000 description 1
- 102100026110 Protein THEMIS2 Human genes 0.000 description 1
- 102100028158 Protein YIPF2 Human genes 0.000 description 1
- 102100028588 Protein ZNRD2 Human genes 0.000 description 1
- 102100021566 Protein kinase C theta type Human genes 0.000 description 1
- 102100022619 Protein naked cuticle homolog 2 Human genes 0.000 description 1
- 102100022321 Protein spinster homolog 3 Human genes 0.000 description 1
- 102100031076 Protein tweety homolog 2 Human genes 0.000 description 1
- 102100020908 Protein zyg-11 homolog B Human genes 0.000 description 1
- 102100033845 Putative gonadotropin-releasing hormone II receptor Human genes 0.000 description 1
- 102100021480 Putative sodium-coupled neutral amino acid transporter 8 Human genes 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 102100039691 RNA-binding protein 8A Human genes 0.000 description 1
- 102000020171 Rab20 Human genes 0.000 description 1
- 108050007545 Rab20 Proteins 0.000 description 1
- 102100033218 Ras association domain-containing protein 8 Human genes 0.000 description 1
- 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 description 1
- 102100033729 Receptor-interacting serine/threonine-protein kinase 3 Human genes 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102100037404 Receptor-type tyrosine-protein phosphatase N2 Human genes 0.000 description 1
- 102100039665 Receptor-type tyrosine-protein phosphatase epsilon Human genes 0.000 description 1
- 102100021043 Regulatory factor X-associated protein Human genes 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 102100029831 Reticulon-4 Human genes 0.000 description 1
- 102100040070 Retinal dehydrogenase 2 Human genes 0.000 description 1
- 102100037593 Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta Human genes 0.000 description 1
- 101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 1
- 102100032437 Rho guanine nucleotide exchange factor 17 Human genes 0.000 description 1
- 102100021689 Rho guanine nucleotide exchange factor 3 Human genes 0.000 description 1
- 102100040312 Ribonuclease 7 Human genes 0.000 description 1
- 108010085025 Ribonuclease 7 Proteins 0.000 description 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
- 108091006419 SLC25A12 Proteins 0.000 description 1
- 108091006512 SLC26A11 Proteins 0.000 description 1
- 108091006927 SLC38A8 Proteins 0.000 description 1
- 108091007001 SLC44A2 Proteins 0.000 description 1
- 108091006253 SLC8A1 Proteins 0.000 description 1
- 101700004678 SLIT3 Proteins 0.000 description 1
- 102100022010 SNF-related serine/threonine-protein kinase Human genes 0.000 description 1
- 102100029754 SS18-like protein 2 Human genes 0.000 description 1
- 229910004444 SUB1 Inorganic materials 0.000 description 1
- 101100379220 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) API2 gene Proteins 0.000 description 1
- 102100038691 Scm-like with four MBT domains protein 2 Human genes 0.000 description 1
- 102100032753 Segment polarity protein dishevelled homolog DVL-2 Human genes 0.000 description 1
- 102100027980 Semaphorin-3C Human genes 0.000 description 1
- 101710199433 Semaphorin-3C Proteins 0.000 description 1
- 102100029726 Serine incorporator 5 Human genes 0.000 description 1
- 102100026757 Serine/threonine-protein kinase 19 Human genes 0.000 description 1
- 102100028030 Serine/threonine-protein kinase 32B Human genes 0.000 description 1
- 101710096798 Serine/threonine-protein kinase DCLK2 Proteins 0.000 description 1
- 102100039985 Serine/threonine-protein kinase ULK3 Human genes 0.000 description 1
- 102100025490 Slit homolog 1 protein Human genes 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical group [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 102100037246 Sodium channel modifier 1 Human genes 0.000 description 1
- 102100030109 Sodium-independent sulfate anion transporter Human genes 0.000 description 1
- 102100035088 Sodium/calcium exchanger 1 Human genes 0.000 description 1
- 102100036043 Synapse differentiation-inducing gene protein 1-like Human genes 0.000 description 1
- 102100040541 Synaptotagmin-like protein 1 Human genes 0.000 description 1
- 102100038409 T-box transcription factor TBX3 Human genes 0.000 description 1
- 102100028866 TATA element modulatory factor Human genes 0.000 description 1
- 102100029869 TBC1 domain family member 16 Human genes 0.000 description 1
- 102100033707 TOM1-like protein 2 Human genes 0.000 description 1
- 102100026749 TOX high mobility group box family member 4 Human genes 0.000 description 1
- 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 description 1
- 102100029222 Teashirt homolog 3 Human genes 0.000 description 1
- 102100024548 Tensin-3 Human genes 0.000 description 1
- 102100035105 Testis-expressed protein 2 Human genes 0.000 description 1
- 102100030168 Testis-specific serine/threonine-protein kinase 3 Human genes 0.000 description 1
- 102100032830 Tetraspanin-9 Human genes 0.000 description 1
- 241001230284 Theclini Species 0.000 description 1
- 102100030269 Thioredoxin domain-containing protein 5 Human genes 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 102100028088 Thyrotropin-releasing hormone-degrading ectoenzyme Human genes 0.000 description 1
- 102100031996 Tolloid-like protein 1 Human genes 0.000 description 1
- 102100028621 Trans-Golgi network integral membrane protein 2 Human genes 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 102100038034 Transcription cofactor vestigial-like protein 4 Human genes 0.000 description 1
- 102100022972 Transcription factor AP-2-alpha Human genes 0.000 description 1
- 102100021382 Transcription factor GATA-6 Human genes 0.000 description 1
- 102100023234 Transcription factor MafB Human genes 0.000 description 1
- 102100027654 Transcription factor PU.1 Human genes 0.000 description 1
- 102100022415 Transcription factor SOX-11 Human genes 0.000 description 1
- 102100036693 Transcription factor SOX-4 Human genes 0.000 description 1
- 102100028864 Transmembrane 6 superfamily member 1 Human genes 0.000 description 1
- 102100036770 Transmembrane channel-like protein 8 Human genes 0.000 description 1
- 102100031986 Transmembrane emp24 domain-containing protein 4 Human genes 0.000 description 1
- 102100036798 Transmembrane protein 147 Human genes 0.000 description 1
- 102100036380 Transmembrane protein 176A Human genes 0.000 description 1
- 102100036387 Transmembrane protein 176B Human genes 0.000 description 1
- 102100033080 Tropomyosin alpha-3 chain Human genes 0.000 description 1
- 102100031935 Tubulin polymerization-promoting protein family member 2 Human genes 0.000 description 1
- 102100024595 Tumor necrosis factor alpha-induced protein 2 Human genes 0.000 description 1
- 102100034131 Tumor necrosis factor alpha-induced protein 8-like protein 2 Human genes 0.000 description 1
- 102000003436 UBA3 Human genes 0.000 description 1
- 108060008744 UBA3 Proteins 0.000 description 1
- 102100029645 UBX domain-containing protein 11 Human genes 0.000 description 1
- 102100037921 UDP-N-acetylglucosamine pyrophosphorylase Human genes 0.000 description 1
- 102100038463 Ubiquitin carboxyl-terminal hydrolase 4 Human genes 0.000 description 1
- 102100021015 Ubiquitin carboxyl-terminal hydrolase 6 Human genes 0.000 description 1
- 102100022061 Uncharacterized protein C14orf132 Human genes 0.000 description 1
- 102100037161 Uncharacterized protein KIAA0895-like Human genes 0.000 description 1
- 102100029150 Uridine-cytidine kinase 2 Human genes 0.000 description 1
- 102100031384 V-type proton ATPase subunit e 2 Human genes 0.000 description 1
- 102100021937 VPS10 domain-containing receptor SorCS1 Human genes 0.000 description 1
- 102100039098 Vacuolar protein sorting-associated protein 72 homolog Human genes 0.000 description 1
- 102100034074 Voltage-gated potassium channel subunit beta-2 Human genes 0.000 description 1
- 102100038159 WD repeat-containing protein 27 Human genes 0.000 description 1
- 102100034655 Zinc finger SWIM domain-containing protein 5 Human genes 0.000 description 1
- 102100040315 Zinc finger and BTB domain-containing protein 14 Human genes 0.000 description 1
- 102100023394 Zinc finger protein 138 Human genes 0.000 description 1
- 102100021377 Zinc finger protein 18 Human genes 0.000 description 1
- 102100027803 Zinc finger protein 528 Human genes 0.000 description 1
- 102100027810 Zinc finger protein 529 Human genes 0.000 description 1
- 102100026496 Zinc finger protein 653 Human genes 0.000 description 1
- 102100026463 Zinc finger protein with KRAB and SCAN domains 1 Human genes 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 208000028922 artery disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
- 102100029168 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human genes 0.000 description 1
- 102100029170 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human genes 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000024149 cardiac muscle tissue development Effects 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 230000033476 cardiovascular system development Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 230000033468 circulatory system development Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 108010030886 coactivator-associated arginine methyltransferase 1 Proteins 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 208000018695 congenital heart malformation Diseases 0.000 description 1
- 208000035196 congenital hypomyelinating 2 neuropathy Diseases 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 101150118453 ctbp-1 gene Proteins 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000012350 deep sequencing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000104 diagnostic biomarker Substances 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000004076 epigenetic alteration Effects 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 230000007608 epigenetic mechanism Effects 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 238000009162 epigenetic therapy Methods 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000021158 homophilic cell adhesion Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007031 hydroxymethylation reaction Methods 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 239000002117 illicit drug Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003455 independent Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 235000019689 luncheon sausage Nutrition 0.000 description 1
- 102100034703 mRNA decay activator protein ZFP36L2 Human genes 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 108091046551 miR-324 stem-loop Proteins 0.000 description 1
- 108091054834 miR-548g stem-loop Proteins 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000017028 multicellular organismal development Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000033087 muscle system process Effects 0.000 description 1
- 238000013164 myectomy Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000003365 myofibril Anatomy 0.000 description 1
- 239000011807 nanoball Substances 0.000 description 1
- 239000002833 natriuretic agent Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000092 prognostic biomarker Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 108010062302 rac1 GTP Binding Protein Proteins 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002235 sarcomere Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000007755 survival signaling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 102100032270 tRNA (cytosine(38)-C(5))-methyltransferase Human genes 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 238000013334 tissue model Methods 0.000 description 1
- 238000013520 translational research Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- SQQWBSBBCSFQGC-JLHYYAGUSA-N ubiquinone-2 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O SQQWBSBBCSFQGC-JLHYYAGUSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Definitions
- the present invention relates to a method of determining markers for a disease from a patient, wherein information from epigenomics and/or the transcriptome from peripheral blood and a diseased tissue or information from epigenomics and the transcriptome from peripheral blood or a diseased tissue is used for obtaining the markers, as well as a method of determining a risk for a disease in a patient using the markers obtained thereby.
- Heart failure is one major cause of morbidity and mor ⁇ tality in the general population and is the leading cause of hospitalization in individuals older than 65.
- HF Heart failure
- HF is the result of an underlying cardiac disease.
- the two most common reasons for developing HF are systolic and/or di- astolic dysfunction.
- systolic HF also referred to as HF- rEF the main reasons are ischemic heart disease due to coro ⁇ nary artery disease and myocardial infarction and non- ischemic causes such as Dilated Cardiomyopathy (DCM) .
- DCM Dilated Cardiomyopathy
- DCM is a frequent heart muscle disease with an estimated prevalence of 1:2500 up to 1:500, which is caused by genetic mechanism, inflammation or infection.
- the progressive nature of the dis- order is responsible for nearly 50,000 hospitalizations and 10,000 deaths per year in the US alone and is the main cause for heart transplantation in young adults.
- Nt-ProBNP N-terminal pro b-type natriuretic peptide
- Heart failure is the leading cause of hospitalization and death in Western countries. Over the last decades the genetic causes and molecular events driving the progression of heart failure have only been partially unravelled. Besides genetic predisposition (Meder B, et al . , A genome-wide association study identifies 6p21 as novel risk locus for dilated cardio- myopathy. Eur Heart J. 2014;35:1069-77; Villard E, et al . , A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J. 2011;32:1065-76), it is long known that additional aspects including environmental factors and life-style influence the outbreak and course of myocardial failure (Hang CT, et al .
- DCM Dilated Cardi- omyopathy
- Methyl-CpG-binding protein 2 (MeCP2), a downstream effector of DNA methylation, to be repressed dur- ing heart failure in humans and reactivated after mechanical unloading of the left ventricle by assist devices (Mayer SC, et al . , Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure.
- Biochemical DNA modification resembles a crucial regulatory layer between genetic information, environmental factors and the transcriptome .
- the inventors performed the first multi-omics study in myo ⁇ cardial tissue and blood of patients with Dilated Cardiomyo ⁇ pathy (DCM) and controls.
- DCM Dilated Cardiomyo ⁇ pathy
- the present inventors dissected for the first time high- resolution epigenome-wide cardiac and blood DNA methylation in conjunction with mRNA and whole-genome sequencing in a large cohort of densely-phenotyped patients with systolic heart failure due to DCM. They provide the yet largest da- taset of cardiac and blood DNA methylation profiles and iden ⁇ tified key epigenomic patterns that are distinct fingerprints of human heart failure.
- the present inventors have found that improved marker finding is possible when more than one characteristic of the sample, e.g. the nucleic acid sequence, is considered. Further, it was found that also improved marker finding is possible when more than one sample from different sources is considered, wherein one if preferably from tissue related to a disease and a further one from peripheral blood.
- the present invention is related to a method of determining markers for a disease from a patient, comprising
- the present invention relates to a method of deter ⁇ mining markers for a disease from a patient, comprising
- a method of determining a risk for a disease in a patient comprising
- determining the presence of at least one marker as de ⁇ termined by the method of the first or second aspect is dis- closed.
- a data bank comprising specific markers for heart failure and/or dilated cardiomyopathy in a patient
- this databank in a method of determining a risk for heart failure and/or dilated cardiomyopathy in a patient
- the use of the specific markers as a marker for heart failure and/or dilated cardiomyopathy in a patient.
- a method of determining a risk for a disease in a patient comprising
- determining the presence of at least one marker as de- termined by the method of the first or second aspect is dis ⁇ closed, as well as a computer program product comprising computer executable instructions which, when executed, perform such a method. Further aspects and embodiments of the invention are dis ⁇ closed in the dependent claims and can be taken from the fol ⁇ lowing description, figures and examples, without being limited thereto. Figures
- Figs. 1 to 3 show schematically concepts for finding markers for a disease according to a method of the present invention.
- Fig. 4 shows the relation between Simes significance level (SL) for association between DNA methylation and gene expression at increasing distances (D) as determined in the present Example 1.
- Figures 5 to 21 show data referred to and obtained in present Example 2.
- nucleic acid molecule refers to a polynucleotide molecule having a defined sequence. It comprises DNA mole ⁇ cules, RNA molecules, nucleotide analog molecules and combi ⁇ nations and derivatives thereof, such as DNA molecules or RNA molecules with incorporated nucleotide analogs or cDNA.
- nucleic acid sequence information relates to in ⁇ formation which can be derived from the sequence of a nucleic acid molecule, such as the sequence itself or a variation in the sequence as compared to a reference sequence.
- mutation relates to a variation in the sequence as compared to a reference sequence.
- a mutation is for example a deletion of one or multiple nucleotides, an insertion of one or multiple nucleotides, or substitution of one or multiple nucleotides, duplication of one or a sequence of multiple nu ⁇ cleotides, translocation of one or a sequence of multiple nu- cleotides, and, in particular, a single nucleotide polymor ⁇ phism (SNP) .
- SNP single nucleotide polymor ⁇ phism
- a “sample” is a sam ⁇ ple which comprises at least epigenetic information and/or information regarding the transcriptome of a patient.
- Exam ⁇ ples for samples are: cells, tissue, biopsy specimens, body fluids, blood, urine, saliva, sputum, plasma, serum, cell culture supernatant, swab sample and others.
- An epigenomics profile corresponds to the multitude of all epigenomic modifications, i.e. DNA methylation, Histone meth- ylation, etc., that can occur in a patient.
- a transcriptomics profile corresponds to the multitude of all transcribed nucleic acids, i.e. messenger RNA, micro RNAs, non-coding RNAs, etc.
- Peripheral blood refers to the circulating pool of blood within the patient.
- the patient in the present methods is a vertebrate, more preferably a mammal and most preferred a human patient.
- a vertebrate within the present invention refers to animals having a vertebrae, which includes mammals - including hu ⁇ mans, birds, reptiles, amphibians and fishes.
- the present in ⁇ vention thus is not only suitable for human medicine, but al ⁇ so for veterinary medicine.
- next generation sequencing or “high throughput sequencing” refers to high-throughput sequencing technologies that parallelize the sequencing process, producing thousands or millions of sequences at once. Examples include Massively Parallel Signa ⁇ ture Sequencing (MPSS) , Polony sequencing, 454 pyrosequenc- ing, Illumina (Solexa) sequencing, SOLiD sequencing, Ion semiconductor sequencing, DNA nanoball sequencing, Helioscope (TM) single molecule sequencing, Single Molecule
- SMRT(TM) sequencing Single Molecule real time (RNAP) se ⁇ quencing, Nanopore DNA sequencing, Sequencing By Hybridization, Amplicon Sequencing, GnuBio.
- the present invention relates to a method of determining markers for a disease from a patient, compris ⁇ ing
- two samples are provided, e.g. from a human, i.e. one sample from a diseased tissue 1, e.g. the my- ocard, and one sample from peripheral blood 2.
- the epigenomics profile 3 and the transcriptome 4 are obtained and analyzed with the present method, to obtain one or more markers 5.
- only the epigenomics profile 3 or the transcriptome 4 can be obtained and analyzed when two samples are provided (not shown) .
- only either the epigenomics profile 3 or the transcriptome 4 are then analyzed from both samples in such a case, i.e. not the epigenomics profile 3 from one sample and the transcriptome 4 from the other sample.
- the present invention relates to a method of determining markers for a disease from a patient, compris ⁇ ing
- one sample is provided, e.g. from a hu- man, i.e. one sample from a diseased tissue 1, e.g. the myo- card.
- a diseased tissue 1 e.g. the myo- card.
- both the epigenomics profile 3 and the transcriptome 4 are obtained and analyzed with the present method, to obtain one or more markers 5.
- it is al ⁇ so possible to provide one sample from the peripheral blood 2 instead of from the diseased tissue 1 in this method, though.
- the disease in the present invention is not particularly limited. According to certain embodiments, it is a non ⁇ infectious disease, particularly a cardiovascular disease. According to certain embodiments, the disease is heart fail ⁇ ure (HF) and/or dilated cardiomyopathy (DCM) . In such a case, the sample of the diseased tissue can be obtained from myo ⁇ cardial tissue.
- HF heart fail ⁇ ure
- DCM dilated cardiomyopathy
- the obtaining of the sample is also not particularly limited, but is preferably non-invasive, e.g. is taken from a stock or from a storage, etc.
- the obtaining of the epigenomics profile as well as the analysis of the transcriptome are not particular- ly limited and can be suitably carried out using known means, including sequencing, bead array or microarray technology.
- the comparison to an epigenomics profile and/or a tran ⁇ scriptome of a suitable control is not particularly limited and can be done in any way, e.g. using computational pro ⁇ grams, etc.
- the alteration in the epigenomics pro ⁇ file and/or the transcriptome is not particularly limited.
- the alteration is a hyper and/or hypo methylation and/or a change in chromatin marks and/or a change in the RNA (e.g. messenger RNA, micro RNA, non-coding RNA etc.) expression level, e.g. an increase or decrease in RNA expression level, wherein all combinations are possible, e.g. a hyper methylation in combination with a decrease or an increase in RNA expression level, or a hypo methylation in combination with a decrease or an increase in RNA expression level.
- RNA e.g. messenger RNA, micro RNA, non-coding RNA etc.
- the control is not limited as well and can be suitably chosen based on the patient.
- a control can be obtained from one or more patients not diagnosed with the disease, or from a publicly known control that is not affected by the disease.
- the one or more alteration is determined with regard to the nucleic acid se ⁇ quence information of the patient, e.g. the genome.
- the patient is a human.
- the patient is a human and the control is reference genome hgl9, as provided by e.g. Genome Refer- ence Consortium and the University of California, Santa Cruz (GRCh37/hgl9, downloadable from
- a plurality of samples of the peripheral blood and/or the diseased tissue are obtained or provided from patients diagnosed with the disease. This way statistical significance of the found markers can be im ⁇ proved .
- the present invention relates to a meth- od of determining a risk for a disease in a patient, compris ⁇ ing
- the obtaining of the sample is not particularly lim- ited, but is preferably non-invasive, e.g. is taken from a stock or from a storage, etc.
- the diseased tissue is the myocard, and preferably the disease is heart failure and/or dilated cardiomyopathy.
- the at least one epi- genetic and / or transcriptomic marker for determining a risk for heart failure and/or dilated cardiomyopathy is shown in the following tables.
- genomic regions with regard to reference genome hgl9 that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myocardial tissue and are as ⁇ sociated with RNA expression levels and is chosen from the sequences disclosed in Table 1, preferably Table la, particu ⁇ larly preferably Table lb; and/or
- - is contained in genomic regions with regard to reference genome hgl9 that show hyper/hypo methylation in HF/DCM in myocardial tissue and are associated with RNA expression levels and is chosen from the sequences disclosed in Table 2, pref ⁇ erably Table 2a, particularly preferably Table 2b; and/or - is contained in genomic regions with regard to reference genome hgl9 that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myocardial tissue and is cho ⁇ sen from the sequences disclosed in Table 3, preferably Table 3a, particularly preferably Table 3b; and/or
- - is contained in genomic regions with regard to the refer- genome hgl9, respectively, that show dysmethylation in HF/DCM in peripheral blood and is chosen from the cpg IDs or posi ⁇ tions disclosed in Table 7; and/or - is contained in genomic regions with regard to reference genome hgl9 that show dysmethylation in HF/DCM in peripheral blood and is chosen from the sequences disclosed in Table 8 ; and/or
- - is contained in genomic regions with regard to reference genome hgl9 that show dysmethylation in HF/DCM in peripheral blood and myocardial tissue and are associated with RNA ex ⁇ pression levels and is chosen from the ANF and/or BNP loci and/or the sequences disclosed in Table 10.
- the sequences are the nucleic acid sequences between the positions in the columns titled start and end in the respective chromosomes (chr.), including the positions given under start and end, with regard to reference genome hgl9.
- Tables 1, 2, 3, 4, 6, 8, and 10 thus represent the respective ranges for a gene range -10000 base pairs at the start and +10000 at the end for genes affected by a change in methylation, i.e. a hyper/hypo methylation, whereas tables la, 2a and 3a represent the sequence ranges for the affected gene, and tables lb, 2b and 3b represent the most significant methylation alterations.
- Table 1 Markers, given as nucleic acid sequence with start and end, that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myocardial tissue and are as ⁇ sociated with RNA expression levels (with regard to reference genome hgl9)
- Table la Preferred markers, given as nucleic acid sequence with start and end, that show coordinated hyper/hypo methyla tion in HF/DCM in peripheral blood and myocardial tissue and are associated with RNA expression levels (with regard to reference genome hgl9)
- start end chr start end chr .
- start end chr start end chr .
- Table lb Particularly preferred markers, given as nucleic acid sequence with start and end, that show coordinated hy ⁇ per/hypo methylation in HF/DCM in peripheral blood and myo ⁇ cardial tissue and are associated with RNA expression levels (with regard to reference genome hgl9)
- Table 2 Markers, given as nucleic acid sequence with start and end, that show hyper/hypo methylation in HF/DCM in myo ⁇ cardial tissue and are associated with RNA expression levels (with regard to reference genome hgl9)
- start end chr start end chr .
- start end chr start end chr .
- Table 2a Preferred markers, given as nucleic acid sequence with start and end, that show hyper/hypo methylation in HF/DCM in myocardial tissue and are associated with RNA ex ⁇ pression levels (with regard to reference genome hgl9) start end chr . start end chr .
- Table 2b Particularly preferred markers, given as nucleic acid sequence with start and end, that show hyper/hypo meth ylation in HF/DCM in myocardial tissue and are associated with RNA expression levels (with regard to reference genome hgl9)
- start end chr start end chr .
- start end chr start end chr .
- Table 3 Markers, given as nucleic acid sequence with start and end, that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myocardial tissue (with regard to reference genome hgl9)
- Table 3a Preferred markers, given as nucleic acid sequence with start and end, that show coordinated hyper/hypo methyl tion in HF/DCM in peripheral blood and myocardial tissue (with regard to reference genome hgl9)
- start end chr start end chr .
- start end chr start end chr .
- Table 3b Particularly preferred markers, given as nucleic acid sequence with start and end, that show coordinated hy ⁇ per/hypo methylation in HF/DCM in peripheral blood and myo ⁇ cardial tissue (with regard to reference genome hgl9) start end chr . start end chr .
- ID numbers for the methylation refer to the In- finium HumanMethylation450 BeadChip Kit probe IDs as listed in the HumanMethylation450 vl.2 Manifest
- table 2 respectively 2a and 2b, has been split in two tables 2c and 2d, since for Table 2d the whole region has been shown to be significantly deregulated on methylation and expression level.
- gene IDs, gene names and chromosomes are also given in Tables 4, 6, 8 and 10.
- Tables 5, 7 and 9 cpg IDs - representing methylation locations (representing either a nucleobase or a paired nu ⁇ cleobase) - are given with regard to the Infinium Hu- manMethylation450K database, and chromosomes and positions (pos) are given with regard to the reference genome.
- Table 4 Markers, given as nucleic acid sequence with start and end, that show dysmethylation in HF/DCM in peripheral blood (with regard to reference genome hgl9)
- the markers m Table 4 represent genomic regions with lOkb up/downstream of genes that show statistically significant, particularly the statistically most significant, validated dysmethylation in peripheral blood, particularly in independ ent discovery (41 DCM and 31 CTRL) and verification cohorts (9 DCM and 28 CTRL) .
- Table 5 Markers, given as cpg ID with regard to the refer ⁇ ence Inf inium HumanMethylation450K database, and as position (pos) , given with regard to the reference genome hgl9, that show dysmethylation in HF/DCM in peripheral blood
- the markers in Table 5 represent distinct cpg IDs and genomic positions (particularly top 10) that show statistically sig ⁇ nificant, particularly the statistically most significant, validated dysmethylation in peripheral blood, particularly in independent discovery (41 DCM and 31 CTRL) and verification cohorts (9 DCM and 28 CTRL) .
- Table 6 Markers, given as nucleic acid sequence with start and end, that show dysmethylation in HF/DCM in peripheral blood (with regard to reference genome hgl9)
- the markers in Table 6 represent genomic regions with lOkb up/downstream of genes that show validated dysmethylation in peripheral blood, particularly in independent discovery (41 DCM and 31 CTRL) and verification cohorts (9 DCM and 28 CTRL) with an area under the curve (AUC) of more than 85% in the discovery and verification cohorts.
- Table 7 Markers, given as cpg ID with regard to the refer- ence Infinium HumanMethylation450K database, and as position (pos) , given with regard to the reference genome hgl9, that show dysmethylation in HF/DCM in peripheral blood
- the markers in Table 7 represent distinct cpg IDs and genomic positions that show validated dysmethylation in peripheral blood, particularly in independent discovery (41 DCM and 31 CTRL) and verification cohorts (9 DCM and 28 CTRL) with an area under the curve (AUC) of more than 85% in the discovery and verification cohorts.
- Table 8 Markers, given as nucleic acid sequence with start and end, that show dysmethylation in HF/DCM in peripheral blood (with regard to reference genome hgl9)
- the markers in Table 8 represent genomic regions with lOkb up/downstream of genes that show validated dysmethylation in peripheral blood, particularly in independent discovery (41 DCM and 31 CTRL) and verification cohorts (9 DCM and 28 CTRL) with an area under the curve (AUC) of more than 80% in the discovery and verification cohorts.
- Table 9 Markers, given as cpg ID with regard to the refer- ence Infinium HumanMethylation450K database, and as position (pos) , given with regard to the reference genome hgl9, that show dysmethylation in HF/DCM in peripheral blood
- the markers in Table 9 represent distinct cpg IDs and genomic positions that show validated dysmethylation in peripheral blood, particularly in independent discovery (41 DCM and 31 CTRL) and verification cohorts (9 DCM and 28 CTRL) with an area under the curve (AUC) of more than 80% in the discovery and verification cohorts.
- Table 10 Markers, given as nucleic acid sequence with start and end, that show dysmethylation in HF/DCM in peripheral blood and myocardial tissue and are associated with RNA ex ⁇ pression levels (with regard to reference genome hgl9)
- the markers in Table 10 represent markers that show dysmeth- ylation in HF/DCM in peripheral blood and myocardial tissue and are associated with RNA expression levels and represent the genes NPPA and NPPB.
- the ANF and BNP loci encode atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) , and the latter represents the present gold-standard biomarker for heart failure.
- NPPA neuropeptide kinase
- NPPB neuropeptide kinase
- Fig. 17 shows therein the DNA methylation of the NPPA and NPPB locus.
- Natriuretic peptides are the gold-standard bi ⁇ omarkers in HF.
- hypomethylation of the 5' CpG is as ⁇ sociated with increased expression.
- the same direc ⁇ tion of dysmethylation is found representing a cross-tissue conservation.
- Hgl9 coordinates for ANF (NPPA) and NPPB loci with lOkb up/downstream window that can serve as biomarker for heart failure are given in table 10.
- NPPA ANF
- BNP loci lOkb up/downstream window
- Table lc Summary of tables 1, la and lb with additional data
- Table 2c Summary of tables 2, 2a and 2b (part 1) with additional data
- Table 2d Summary of tables 2, 2a and 2b (part 2) with additional data
- Table 3c Summary of tables 3, 3a and 3b with additional data
- the presence of a plurality of markers is determined, so that the risk of heart failure and/or dilated cardiomyopathy can be determined more accu ⁇ rately.
- a further aspect of the present invention is directed to the use of the markers in Table 1, Table 2, Table 3, Table 4, Ta ⁇ ble 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, preferably Table la, Table 2a, Table 3a, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, particu ⁇ larly preferably Table lb, Table 2b, Table 3b, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, e.g. Table la, Table 2a and/or Table 3a, e.g. Table lb, Table 2b and/or Table 3b, as a marker for heart failure and/or dilated cardiomyopathy in a patient.
- a data bank comprising the markers disclosed in Table 1, Table 2, Table 3, Table 4, Table 5, Ta ⁇ ble 6, Table 7, Table 8, Table 9 and/or Table 10, preferably Table la, Table 2a, Table 3a, Table 4, Table 5, Table 6, Ta ⁇ ble 7, Table 8, Table 9 and/or Table 10, particularly preferably Table lb, Table 2b and/or Table 3b, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, e.g. Ta ⁇ ble la, Table 2a and/or Table 3a, e.g. Table lb, Table 2b and/or Table 3b, .
- the data bank can be at a remote location and can be queried from a local client.
- the present data banks can be used in a variety of applica ⁇ tions.
- the data bank can then be used, according to an aspect of the invention, in a method of determining a risk for heart failure and/or dilated cardiomyopathy in a patient .
- a data bank comprising markers obtained by the first and/or second aspect of the invention.
- the present invention relates in a further aspect to a method of determining a risk for a disease in a pa ⁇ tient, comprising
- the disease is heart fail ⁇ ure (HF) and/or dilated cardiomyopathy (DCM)
- the at least one marker as determined by the method of first and/or second aspect is at least a marker disclosed in Table 1, Ta ⁇ ble 2, Table 3, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, preferably Table la, Table 2a, Table 3a, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, particularly preferably Table lb, Table 2b, Table 3b, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, e.g. Table la, Table 2a and/or Table 3a, e.g. Table lb, Table 2b and/or Table 3b.
- the present invention relates to a computer program product comprising computer executable instructions which, when executed, perform a method of deter- mining a risk for a disease in a patient.
- the computer program product is one on which program commands or program codes of a computer program for executing said method are stored.
- the computer program product is a storage medium.
- the present invention also relates to the use of the computer program product in a method of determining a risk for a disease in a patient.
- a method of prognosis and/or for moni ⁇ toring and/or assisting in drug-based therapy of patients di- agnosed with heart failure and/or dilated cardiomyopathy wherein a marker as disclosed in Table 1, Table 2, Table 3, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, preferably Table la, Table 2a, Table 3a, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, particularly preferably Table lb, Table 2b, Table 3b, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, e.g. Table la, Table 2a and/or Table 3a, e.g. Table lb, Table 2b and/or Table 3b, is used.
- the markers disclosed in Table 1, Table 2, Table 3, Table 4, Table 5, Table 6, Table 10 is used.
- Table 8 Table 9 and/or Table 10, preferably Table la, Ta ⁇ ble 2a, Table 3a, Table 4, Table 5, Table 6, Table 7, Table
- Table 9 and/or Table 10 particularly preferably Table lb, Table 2b, Table 3b, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9 and/or Table 10, e.g. Table la, Table 2a and/or Table 3a, e.g. Table lb, Table 2b and/or Table 3b, allow a prognosis of the course of the disease as well as a monitor ⁇ ing thereof and can assist in deriving a conclusion regarding the medication prescription, etc., during the therapeutic treatment thereof.
- Multi-omics studies allow detec ⁇ tion of functional patterns in cardiovascular disease. • Epigenetic patterns are associated with heart failure due to dilated cardiomyopathy. The multi-omics studies design furthermore allowed detection of connected functional layers in cardiovascular disease.
- DNA methylation of distinct genomic regions is conserved between heart tissue and peripheral blood. DNA methylation could represent a new class of heart failure biomarkers.
- DCM non ⁇ ischemic Dilated Cardiomyopathy
- CAD coronary artery disease
- Valvular heart disease was excluded by cMRI and/or echocardiography and myocarditis/inflammatory DCM by histopathology .
- Patients with history of uncontrolled hypertension, myocarditis, regular alcohol consumption or cardio-toxic chemotherapy were also excluded.
- EF early disease stages
- Haemoglobin mean ⁇ SD, g/dl 14.4 ⁇ 1.5
- eGFR mean ⁇ SD, mL/min/1.73 m 2 88.6116.3
- NT-proBNP median (1Q;3Q), ng/1 767 (104;2385)
- LV-EDV index mean ⁇ SD, mL/m 2 130+54
- RV-EDD index mean ⁇ SD, mm/m 2 24+4
- ACE angiotensin-converting enzyme
- ARB angiotensin II receptor blocker
- DCM dilated cardiomyopathy
- EDD end- diastolic diameter
- EDV end-diastolic volume
- GFR Glome ⁇ rular filtration rate
- LV left ventricular
- LV-EMB Left- Ventricular Endomyocardial Biopsy n: number
- NYHA New York Heart Association
- SCD sudden cardiac death
- SD standard deviation
- 1Q first quartile
- 3Q third Quartile.
- Biopsy specimens were obtained from the apical part of the free left ventricular wall (LV) from DCM patients or cardiac transplant patients (controls) undergoing cardiac catheteri ⁇ zation using a standardized protocol. Biopsies were immedi ⁇ ately washed in ice-cold saline (0.9% NaCl) and immediately transferred and stored in liquid nitrogen until DNA or RNA was extracted. After diagnostic workup of the biopsies (his- topathology) , remaining material was evenly dissected to iso ⁇ late DNA and RNA. DNA was isolated from biopsies and periph ⁇ eral blood using Qiagen DNA Blood Maxi Kit.
- Methylation profiles were measured using the Illumina 450k methylation assay, following procedures as described in
- Methylation sites with a detection p-value of > 0.05 in more than 10% of the samples were removed from analysis.
- Methyla ⁇ tion levels with a detection p-value of > 0.05 in less than 10% of the samples were imputed via knn-imputation, as de ⁇ scribed in Hastie T, T., R, Narasimhan, B Chu, G, impute: im- pute : Imputation for microarray data, R package version
- Deregulated methylation sites were identified by linear mod- elling and moderated t-tests including age and gender using the limma package, as described above.
- PCs principal components
- DNA methylation of the gene body as well as adjacent non- coding regulatory regions is known to be an important regula ⁇ tion mechanism for gene expression.
- aggregate significance level was then ob ⁇ tained using the simes procedure for all methylation loci as the simes procedure has been shown to generally perform well, also for correlated significance levels, as described in R0DLAND, E.A.: Simes' procedure is Valid on average', Bio- metrika, 93: p. 742-746.
- the simes measure (-loglO simes signifi ⁇ cance level) only starts to drop significantly when increas ⁇ ing the distance from 10.000 to 100.000 bp as until 10.000 bp the difference from 0 bp distance is less than one standard deviation (horizontal lines in the figure, as estimated by 10-fold random sampling with replacement to estimate the standard deviation) .
- a cut-off was chosen at a distance of 10.000 bp.
- Cat. la describes genomic regions that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myo ⁇ cardial tissue and are associated with mRNA expression levels of genes of cardiac relevance in the myocard which are dereg ⁇ ulated in HF/DCM.
- the genes are given in Table 12.
- Cat . lb describes genomic regions that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myo- cardial tissue and are associated with mRNA expression levels of genes of unknown cardiac relevance in the myocard which are deregulated in HF/DCM.
- the genes are given in Table 13.
- Cat. 2 describes genomic regions that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myo ⁇ cardial tissue and cluster in chromosome bands with heart specific genes. The genes are given in Table 14.
- Cat. 3 describes genomic regions that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myo cardial tissue but do not fall within Cat. 1 or 2. Two sub ⁇ categories were identified.
- CcLt ⁇ 3cL is related to genomic regions in genes with cardiac relevance.
- the genes are given in Table 15.
- Cat. 3b is related to genomic regions in genes with unknown cardiac relevance. The genes are given in Table 16. Table 16: Data for Cat. 3b
- Cat. 5 describes genomic regions that show coordinated hyper/hypo methylation in HF/DCM in peripheral blood and myo cardial tissue and are associated with mRNA expression levels in the myocard.
- the genes are given in Table 18.
- Cat. 6 describes genomic regions that show coordinated methylation and gene expression changes in HF/DCM in the myocardial tissue and are also associated with HF/DCM on gene level.
- the genes are given in Table 19.
- Cat. 7 describes genomic regions that show coordinated methylation and gene expression changes in HF/DCM in the myocardial tissue.
- the genes are given in Table 20.
- DCM Dilated Cardiomyopathy
- Controls for whole blood samples had a cardiovascular risk profile (Hypertension, Hyperlipidemia) , but completely normal systolic and di ⁇ astolic left ventricular function without evidence for heart failure or significant (>50%) coronary artery disease.
- Biopsy specimens were obtained from the apical part of the free left ventricular wall (LV) from DCM patients or cardiac transplant patients (controls) undergoing cardiac catheteri- zation using a standardized protocol. Biopsies were immedi ⁇ ately washed in ice-cold saline (0.9% NaCl) and transferred and stored in liquid nitrogen until DNA and RNA was extract ⁇ ed. After diagnostic workup of the biopsies (histopathology) , remaining material was evenly dissected to isolate DNA and RNA. DNA was extracted from blood with DNA Blood Maxi Kit
- RNA pu- rity and concentration were determined using the Bioanalyzer 2100 (Agilent Technologies, Berkshire, UK) with a Eukaryote Total RNA Pico assay for RNA from biopsies and with Eukaryote Total RNA Nano assay for RNA from blood.
- RNA and whole-genome sequencing Methylation profiles were measured using the Illumina 450k methylation assay, following procedures as described earlier (Bibikova M, et al . , High density DNA methylation array with single CpG site resolution. Genomics. 2011;98:288-95). From each patient, we subjected 200ng DNA (blood and biopsy) for the measurements. Methylation sites with a detection p-value of >0.05 in more than 10% of the samples were removed from analysis. Methylation levels with a detection p-value of >0.05 in less than 10% of the samples were imputed via knn- imputation (Hastie T T, R, Narasimhan, B Chu, G.
- genomic DNA was chemically modified with sodium bisulfite.
- the bisulfite-treated DNA was PCR-amplified by primers designed to cover the Infinium probes cg06688621 and cg01642653 (cg06688621 primer sequences GGTGTTTTTTGTTTAGTATTTTTTAGAG and AGGGTAGATTTGAGGTAGTTTAGGA; cg01642653 primer sequences TAGGTGTTTTTTAGGGTTGTTTTTT and GTTGGGGAATTTGTTGTTTATTAG) .
- the amplicons were transcribed by T7 polymerase, followed by T-specific-RNAase-A cleavage.
- the digested fragments were quantified by MALDI-TOF-based tech ⁇ nique (MassARRAY) .
- association statistics, overrepresentation and gene ontology analyses the following is applied.
- Table 21 Confounders for methylation measurements from myo ⁇ cardial tissue in the discovery cohort that are associated with principal components after FDR correction. PCl-4 and 6-7 were subsequently used for correction of potential genomic inflation .
- Table 22 Known confounders for methylation measurements from peripheral blood in the discovery cohort that was identified to be significantly associated with principal components af- ter FDR correction. PCl-4 as well as age and gender were sub ⁇ sequently included for correction of genomic inflation.
- Deregulated methylation sites were identified by linear mod- elling and moderated t-tests including age and gender as well as all identified PCs as covariates using the limma package (Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK. limma powers differential expression analyses for RNA- sequencing and microarray studies. Nucleic Acids Res.
- RNA sequencing libraries were generated using TrueSeq RNA Sample Prep Kit (Illumina) and sequencing was performed
- Genome Biol. 2014 ; 15 : 550 which is an im ⁇ proved method of the variance stabilization transformation (Anders S and Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010 ; 11 : RIO 6) as recommend ⁇ ed for eQTL by the original MatrixEQTL publication (Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics . 2012;28:1353-8).
- missMethyl package Phipson B, Maksimovic J and Oshlack A. missMethyl: an R package for analyzing data from Illumina's HumanMethylation450 platform. Bi- oinformatics . 2016;32:286-8), taking into account the proba ⁇ bility of differential methylation based on the number of probes on the 450k array per gene.
- Table 23 Binding-site Overrepresentation in DMR (Tissue Screening) .
- Haemoglobin mean ⁇ SD, g/dl 14.311.5 eGFR, mean ⁇ SD, mL/min/1.73 m 2 87.4117.8
- NT-proBNP median (1Q 3Q), ng/1
- LV-EDV index mean ⁇ SD, mL/m 2 126.1+44.3 LV-EDD mm ⁇ SD, mm 61.2+9.8
- RV-EDD mean ⁇ SD, mm 48.017.8
- ACE angiotensin-converting enzyme
- ARB angiotensin II receptor blocker
- DCM dilated cardiomyopathy
- EDD end- diastolic diameter
- EDV end-diastolic volume
- GFR Glomeru ⁇ lar filtration rate
- LV left ventricular
- n number
- NYHA New York Heart Association
- SCD sudden cardiac death
- SD standard deviation
- 1Q first quartile
- 3Q third Quartile.
- Haemoglobin mean ⁇ SD, g/dl 12.7+2.1
- ACE angiotensin-converting enzyme
- ARB angiotensin II receptor blocker
- EMB endomyocardial biopsy
- n number
- SD standard deviation
- Haemoglobin mean ⁇ SD, g/dl 14.411.1
- ACE angiotensin-converting enzyme
- ARB angiotensin II receptor blocker
- n number
- SD standard deviation.
- NT-proBNP median (1Q,3Q), ng/1 5641 (2201; 10309)
- ACE angiotensin-converting enzyme
- ARB angiotensin II receptor blocker
- DCM dilated cardiomyopathy
- EDD end- diastolic diameter
- LV left ventricular
- n number
- NYHA New York Heart Association
- SD standard deviation
- 1Q first quartile
- 3Q third Quartile.
Abstract
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16178413 | 2016-07-07 | ||
EP16189099 | 2016-09-16 | ||
EP17171336 | 2017-05-16 | ||
PCT/EP2017/066941 WO2018007525A2 (en) | 2016-07-07 | 2017-07-06 | Epigenome-wide association study identifies cardiac developmental gene patterning and a novel class of biomarkers for heart failure |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3455377A2 true EP3455377A2 (en) | 2019-03-20 |
Family
ID=60921584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17739929.2A Withdrawn EP3455377A2 (en) | 2016-07-07 | 2017-07-06 | Epigenome-wide association study identifies cardiac developmental gene patterning and a novel class of biomarkers for heart failure |
Country Status (5)
Country | Link |
---|---|
US (1) | US20200181703A1 (en) |
EP (1) | EP3455377A2 (en) |
JP (1) | JP2019522997A (en) |
CN (1) | CN109996893A (en) |
WO (1) | WO2018007525A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201902077D0 (en) * | 2019-02-14 | 2019-04-03 | Univ College Dublin Nat Univ Ireland Dublin | Biomarkers |
US11562057B2 (en) | 2020-02-05 | 2023-01-24 | Quantum Digital Solutions Corporation | Ecosystem security platforms for enabling data exchange between members of a digital ecosystem using digital genomic data sets |
JP2024507719A (en) | 2021-02-04 | 2024-02-21 | クアンタム デジタル ソリューションズ コーポレーション | Ciphergenics-based ecosystem security platform |
CN113416783A (en) * | 2021-07-08 | 2021-09-21 | 湖南灵康医疗科技有限公司 | Detection primer composition for NLRP3 promoter methylation, application and detection method |
WO2024029988A1 (en) * | 2022-08-04 | 2024-02-08 | 연세대학교 산학협력단 | Biomarker composition, kit and information provision method for predicting coronary collateral circulation by using cell-free dna |
CN115497561B (en) * | 2022-09-01 | 2023-08-29 | 北京吉因加医学检验实验室有限公司 | Methylation marker layered screening method and device |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2650387T3 (en) * | 2012-03-14 | 2018-01-18 | Ruprecht-Karls-Universität Heidelberg | Epigenetic signatures as a marker of cardiomyopathies and myocardial insufficiencies |
CN103451284B (en) * | 2013-08-22 | 2015-03-18 | 中国科学院生物物理研究所 | Group of novel molecular markers of one group of human myocardial cells, and applications of novel molecular markers |
PT3083997T (en) * | 2013-12-20 | 2020-11-03 | Univ Lausanne | Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine |
-
2017
- 2017-07-06 US US16/315,129 patent/US20200181703A1/en not_active Abandoned
- 2017-07-06 EP EP17739929.2A patent/EP3455377A2/en not_active Withdrawn
- 2017-07-06 CN CN201780053756.4A patent/CN109996893A/en active Pending
- 2017-07-06 JP JP2019500508A patent/JP2019522997A/en active Pending
- 2017-07-06 WO PCT/EP2017/066941 patent/WO2018007525A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018007525A2 (en) | 2018-01-11 |
WO2018007525A3 (en) | 2019-01-10 |
US20200181703A1 (en) | 2020-06-11 |
CN109996893A (en) | 2019-07-09 |
JP2019522997A (en) | 2019-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meder et al. | Epigenome-wide association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure | |
EP3455377A2 (en) | Epigenome-wide association study identifies cardiac developmental gene patterning and a novel class of biomarkers for heart failure | |
Zhou et al. | Epigenome-wide association analysis identified nine skin DNA methylation loci for psoriasis | |
KR102264761B1 (en) | Methods for predicting risk of interstitial pneumonia | |
US11591655B2 (en) | Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies | |
EP2162459B1 (en) | Transcriptomic biomarkers for individual risk assessment in new onset heart failure | |
Yang et al. | Heart failure: advanced development in genetics and epigenetics | |
CA2602543C (en) | Use of gene activity classificators for in vitro classification of gene expression profiles of patients with infectious/non-infectious multiple organ failure | |
JP2014508525A (en) | Method for identifying a subset of polynucleotides for in vitro determination of the severity of a patient's host response from an initial set of polynucleotides corresponding to the human genome | |
JP2018527886A (en) | Predictive gene signature of metastatic disease | |
US20200188356A1 (en) | Novel Circular RNA Biomarkers for Heart Failure | |
Tomaszewski et al. | Kidney omics in hypertension: from statistical associations to biological mechanisms and clinical applications | |
Chouvarine et al. | RNA expression profiles and regulatory networks in human right ventricular hypertrophy due to high pressure load | |
EP3583229A1 (en) | Dna methylation signatures for determining a survival probability | |
WO2011044927A1 (en) | A method for the diagnosis or prognosis of an advanced heart failure | |
EP2657348B1 (en) | Diagnostic miRNA profiles in multiple sclerosis | |
WO2019143828A2 (en) | Biomarkers of cardiovascular status and uses therof | |
CN105431552B (en) | Use of multiomic markers for predicting diabetes | |
Lujan et al. | A CellAgeClock for expedited discovery of anti-ageing compounds | |
KR102085663B1 (en) | Method for providing information of prediction and diagnosis of small vessel occlusion using methylation level of WRB gene and composition therefor | |
KR102085669B1 (en) | Method for providing information of prediction and diagnosis of small vessel occlusion using methylation level of CYP26C1 gene and composition therefor | |
WO2011128646A2 (en) | Genetic markers for paget's disease | |
KR20160044179A (en) | Single nucleotide polymorphism markers for diagnosing and predicting rheumatism in early stage and method for genotyping alleles specific to rheumatism using the same | |
WO2015168252A1 (en) | Mitochondrial dna copy number as a predictor of frailty, cardiovascular disease, diabetes, and all-cause mortality | |
KR20140123464A (en) | Polynucleotide Marker Composition for Diagnosis of Susceptibility to Crohn's Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181214 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KELLER, ANDREAS Inventor name: STAEHLER, CORD, FRIEDRICH Inventor name: POSCH, ANDREAS EMANUEL Inventor name: WUERSTLE, MAXIMILIAN Inventor name: HAAS, JAN Inventor name: SEDAGHAT-HAMEDANI, FARBOD Inventor name: KATUS, HUGO A. Inventor name: MEDER, BENJAMIN |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210311 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20230627 |